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1. Summary 
Fatty acids are essential for the cellular metabolism but their uptake has to be tightly 
regulated to prevent fatty acid associated diseases. Proteins that facilitate fatty acid 
uptake include CD36, FATP4, ACSL1 and Caveolin-1. CD36, FATP4 and ACSL1 
increase oleate uptake upon overexpression. CD36 is an integral transmembrane 
glycoprotein that directly facilitates fatty acid uptake across the plasma membrane. 
The structural protein Caveolin-1 binds fatty acids and is discussed as potential 
interaction partner for CD36. The acyl-CoA synthetases FATP4 and ACSL1 are 
localized intracellularly and activate fatty acids by esterification with coenzyme A, 
thus driving fatty acid uptake indirectly by metabolic trapping.  
This study was designed to 1) quantify absolute protein amounts of CD36, FATP4 
and ACSL1 proteins in overexpressing cell lines and calculate protein specific oleate 
uptake 2) test CD36, FATP4, ACSL1 and Caveolin-1 for cooperativity in facilitating 
fatty acid uptake.  
MDCK cells were chosen as an unspecialized and unbiased model system and 
overexpressing cells were generated by retroviral and adenoviral infection. Infection 
of MDCK cells with increasing amounts of CD36 or FATP4 adenovirus resulted in 
enhanced fatty acid uptake as measured by incubation with radiolabeled oleic acid 
for three hours. Protein amounts of CD36 and FATP4 were analyzed by western 
blotting and absolute protein quantities were calculated by correlation to a 
recombinant protein standard. Increases in fatty acid uptake correlated to rising 
protein amounts of CD36 and FATP4 in accordance with rising adenovirus quantities 
used for infection.  
Comparison of CD36 and FATP4 expression showed a significant difference in 
protein quantities whereas the difference in oleate uptake was much smaller: 13 ng 
CD36 protein increased oleate uptake by 20 % whereas 701 ng FATP4 protein 
resulted in 37 % enhancement. When CD36 and FATP4 were expressed at equal 
quantities, oleate uptake was still enhanced  more by 10 ng CD36 protein as by 10 ng 
FATP4 protein (27 % versus 4 %, respectively), indicating that CD36 is more 
efficient in increasing fatty acid uptake than FATP4. The function of CD36 in fatty 
acid transport of MDCK cells was independent from Caveolin-1, as an 80 % knock 
down of  Caveolin-1 did not alter CD36 dependent oleate uptake. 
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Immunofluorescence analysis confirmed the localization of CD36 to the plasma 
membrane whereas FATP4 localized to the endoplasmic reticulum and ACSL1 was 
expressed at mitochondria. Co-expression of CD36 and FATP4 enhanced oleate 
uptake significantly more than calculated from single protein overexpression, 
resulting in an increase by 49 pmol oleate/µg total protein for co-expressing cells as 
compared to 10 pmol oleate/µg total protein for CD36 and 21 pmol oleate/µg total 
protein for FATP4 overexpressing cells. Oleate uptake was similarly increased in 
CD36 and ACSL1 co-expressing cells whereas FATP4 and ACSL1 together 
enhanced fatty acid uptake less than calculated from single protein overexpression: 
oleate uptake was increased by 30 pmol oleate/µg total protein in co-expressing cells 
as compared to 26 pmol oleate/µg total protein in FATP4 and 15 pmol oleate/µg total 
protein in ACSL1 cells. 
In conclusion, CD36, FATP1 and ACSL1 enhance fatty acid uptake by two different 
mechanisms: CD36 directly facilitates fatty acid transport across the plasma 
membrane whereas FATP4 and ACSL1 indirectly mediate fatty acid uptake by 
metabolic trapping of intracellular fatty acids. CD36 is expressed at significantly 
lower protein amounts than FATP4 but increases fatty acid uptake more than FATP4 
when expressed at similar quantities. The two acyl-CoA synthetases FATP4 and 
ACSL1 target similar metabolic processes and therefore show no cooperativity in 
fatty acid uptake. As both enzyme act intracellularly, their impact on fatty acid 
uptake is limited by the transport rate of fatty acids across the plasma membrane. 
CD36 cooperates with FATP4 and ACSL1 in enhancing oleate uptake, probably due 
to an efficient combination of facilitated fatty acid transport across the plasma 
membrane by CD36 followed by immediate intracellular fatty acid activation by 
FATP4 and ACSL1.  
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2. Zusammenfassung 
Fettsäuren sind essentiell für den zellulären Stoffwechsel jedoch muss ihre 
Aufnahme streng reguliert werden, um Erkrankungen zu vermeiden. Die Aufnahme 
von Fettsäuren in Zellen wird durch Proteine wie CD36, FATP4, ACSL1 und 
Caveolin-1 vermittelt, von denen CD36, FATP4 und ACSL1 die Fettsäureaufnahme 
nach Proteinüberexpression steigern. CD36 ist ein glykosyliertes 
Transmembranprotein, welches direkt die Aufnahme von Fettsäuren über die 
Plasmamembran fördert. Als potentieller Interaktionspartner für CD36 wird das 
Strukturprotein Caveolin-1 diskutiert, welches Fettsäuren bindet. Die Acyl-CoA-
Synthetasen FATP4 und ACSL1 sind intrazellulär lokalisiert und aktivieren 
Fettsäuren durch Veresterung mit Coenzym A, wodurch die Fettsäureaufnahme 
indirekt durch metabolic trapping gesteigert wird.  
Ziele dieser Arbeit waren 1) die Quantifizierung absoluter Proteinmengen von CD36, 
FATP4 und ACSL1 in überexprimierenden Zelllinien und die Berechnung der 
Protein-spezifischen Oleataufnahme 2) die Untersuchung von CD36, FATP4, 
ACSL1 und Caveolin-1 auf Kooperativität bei der Vermittlung der 
Fettsäureaufnahme.   
Als Modelsystem wurden MDCK Zellen gewählt und überexprimierende Zellen 
durch retrovirale und adenovirale Infektion generiert. Die Infektion von MDCK 
Zellen mit steigenden Mengen von CD36 und FATP4 Adenovirus resultierte nach 
Inkubation mit radioaktiv markierter Ölsäure über drei Stunden in einer gesteigerten 
Fettsäureaufnahme. Die Proteinmengen von CD36 und FATP4 wurden mittels 
Western Blot analysiert und absolute Proteinmengen durch Korrelation mit einem 
rekombinanten Proteinstandard berechnet. Der Anstieg der Fettsäureaufnahme 
korrelierte mit den zunehmenden Proteinmengen von CD36 und FATP4 in 
Übereinstimmung mit den für die Infektion genutzten ansteigenden 
Adenovirusmengen.  
Ein Vergleich der Proteinexpression von CD36 und FATP4 ergab eine signifikante 
Differenz der Proteinmengen wohingegen die Unterschiede in der Oleataufnahme 
deutlich geringer waren: 13 ng CD36 Protein erhöhten die Oleataufnahme um 20 % 
wohingegen 701 ng FATP4 Protein in einer Steigerung der Oleataufnahme um 37 % 
resultierten. Bei der Expression gleicher Mengen von CD36 und FATP4 Protein 
wurde die Oleataufnahme durch 10 ng CD36 Protein mehr gesteigert als durch 10 ng 
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FATP4 Protein (27 % im Vergleich zu 4 %). Dies deutet darauf hin, dass CD36 die 
Fettsäureaufnahme effizienter erhöht als FATP4. Die Funktion von CD36 im 
Fettsäuretransport von MDCK Zellen war unabhängig von Caveolin-1, da ein 
80 %iger knock down des Caveolin-1 Proteins die CD36 vermittelte Oleataufnahme 
nicht beeinflusste.  
Durch Immunfluoreszenzanalyse wurde die Lokalisation von CD36 an der 
Plasmamembran bestätigt wohingegen FATP4 auf dem Endoplasmatischen 
Retikulum und ACSL1 auf den Mitochondrien exprimiert wurden. Die Koexpression 
von CD36 und FATP4 steigerte die Oleataufnahme signifikant mehr als basierend 
auf der Überexpression der einzelnen Proteine berechnet und resultierte in einem 
Anstieg um 49 pmol Oleat/µg Gesamtprotein für koexprimierende Zellen verglichen 
mit einer Steigerung um 10 pmol Oleat/µg Gesamtprotein für CD36 und 21 pmol 
Oleat/µg Gesamtprotein für FATP4 überexprimierende Zellen. Die Oleataufnahme 
war in ähnlicher Weise in CD36 und ACSL1 koexprimierenden Zellen erhöht. Die 
gemeinsame Expression von FATP4 und ACSL1 hingegen steigerte die 
Fettsäureaufnahme weniger als ausgehend von der Überexpression der einzelnen 
Proteine berechnet, sodass in koexprimierenden Zellen die Oleataufnahme um 
30 pmol Oleat/µg Gesamtprotein erhöht wurde verglichen mit einem Anstieg um 
26 pmol Oleat/µg Gesamtprotein in FATP4 und 15 pmol Oleat/µg Gesamtprotein in 
ACSL1 überexprimierenden Zellen.  
Es lässt sich schlussfolgern, dass CD36, FATP4 und ACSL1 die Fettsäureaufnahme 
durch zwei verschiedene Mechanismen steigern: CD36 vermittelt direkt den 
Fettsäuretransport über die Plasmamembran während FATP4 und ACSL1 die 
Fettsäureaufnahme indirekt durch metabolic trapping intrazellulärer Fettsäuren 
beeinflussen. CD36 wird in signifikant geringeren Proteinmengen exprimiert als 
FATP4 aber steigert die Fettsäureaufnahme mehr als FATP4 bei vergleichbarer 
Proteinexpression. Die beiden Acyl-CoA-Synthetasen FATP4 und ACSL1 wirken 
auf ähnliche metabolische Prozesse. Da beide Enzyme intrazellulär agieren, ist ihr 
Einfluss auf die Fettsäureaufnahme durch die Transportrate von Fettsäuren über die 
Plasmamembran limitiert, so dass sie keine Kooperativität in der Fettsäureaufnahme 
zeigen. CD36 kooperiert mit FATP4 und ACSL1 in der Erhöhung der Fettsäureauf-
nahme, vermutlich aufgrund einer effizienten Kombination von erleichterter 
Fettsäureaufnahme über die Plasmamembran durch CD36 gefolgt von einer 
unmittelbaren intrazellulären Aktivierung der Fettsäuren durch FATP4 und ACSL1. 
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3. Introduction 
3.1 Fatty acid metabolism 
3.1.1 Properties and functions of fatty acids 
Lipids are essential for life. Together with proteins and carbohydrates they make up 
the most important components of mammalian nutrition, thus enabling and sustaining 
animal and human life. The term lipid describes various subgroups of hydrophobic or 
amphiphilic molecules which are important for energy supply, needed as building 
blocks for cellular membranes and play a role in intracellular signaling.  
The hydrophobic properties of many lipids are caused by fatty acids. All fatty acids 
are composed of a hydrocarbon chain coupled to a carboxylic acid group at one end. 
Although fatty acids vary in chain length and degree of saturation, most naturally 
occurring fatty acids have an even number of carbon atoms, including long-chain and 
very long-chain fatty acids with 14 – 24 carbon atoms. Short chain fatty acids play a 
role especially in the intestine where they may modulate colonic health (Wong et al., 
2006). The hydrocarbon chains of fatty acids are typically unbranched and can 
include one or more double bonds, usually in cis conformation. In polyunsaturated 
fatty acids double bonds are set apart by at least one methylen group. Most 
commonly occurring are the saturated fatty acids palmitic acid (16:0) and stearic acid 
(18:0) as well as their unsaturated counterparts palmitoleic acid (16:1) and oleic acid 
(18:1) (Berg JM, 2003). Some fatty acids cannot be synthesized by the human 
organism itself and must be taken up by nutrition. These essential fatty acids are 
linoleic (18:2) and linolenic (18:3) acid.  
The tasks performed by fatty acids are diverse and range from energy supply over 
cellular signaling and posttranslational modification to membrane synthesis. Lipid 
droplets serve as intracellular, specialized storage organelles: a neutral lipid core, 
mainly consisting of triglycerides and cholesterol esters, is surrounded by a 
phospholipid monolayer covered with perilipin family proteins. If energy is required, 
e.g. during physical exercise, triglycerides are split into glycerol and free fatty acids 
which are released in the bloodstream and transported to the peripheral target tissues 
(Ducharme and Bickel, 2008). Fatty acids are also involved in regulating cellullar 
processes by functioning as signaling molecules, such as eicosanoids (reviewed by 
(Funk, 2001)). The eicosanoids include three different subgroups, prostaglandins, 
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leukotrienes and thromboxanes that are mostly derived from one common precursor 
molecule, the arachidonic acid. Eicosanoids have an influence on various processes, 
including inflammation, antilipolytic activity and platelet aggregation. One of the 
most prominent features of fatty acids is their contribution to the construction of 
cellular membranes. Lipid membranes are essential for cell viability and enable the 
establishment of separate functional units within a cell or between different cells. 
Glycerophospholipids like phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylserine, phosphatidylinositol and phosphatidic acid are the major 
components of cell membranes, with phosphatidylcholine contributing to over 50 % 
to eukaryotic membrane phospholipids. Cholesterol is the predominant sterol of 
mammalian membranes and together with phosphatiylcholine has a strong impact on 
membrane fluidity. Sphingolipids with saturated or unsaturated fatty acid side chains 
make up the third group of membrane lipids (reviewed by (van Meer et al., 2008)). 
Imbalances in fatty acid metabolism can have severe consequences. An excess of 
fatty acids may result in accumulation of triacylglycerol in various organs, such as 
liver, heart, muscle and pancreas. In consequence, normal cellular functions are 
disturbed, resulting in apoptosis and impaired insulin signaling, caused by 
lipotoxicity (reviewed by (Li et al., 2010)). Furthermore, irregulations in lipid 
homeostasis were linked to the onset and progression of non-alcoholic fatty liver 
disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Elevated serum 
amounts of free fatty acids have been identified in liver biopsies from obese NASH 
patients (Bechmann et al., 2010), correlating excess fatty acids with a pathological 
inflammation of the liver. Starting with an obese condition, excess in fatty acids may 
also contribute to the development of the metabolic syndrome, type 2 diabetes, 
artherosclerosis and cardiovascular disease, thus emphasizing the importance of 
careful regulation of lipid metabolism.   
 
3.1.2 Cellular fatty acid uptake 
The uptake of fatty acids is a general process found in many cell types. Fatty acids 
are bound to albumin and transported in the blood to their target tissues. In order to 
be further utilized, fatty acids dissociate from their carrier protein and are taken up 
into the cells. Intracellular fatty acids are then activated by esterification with 
coenzyme A (CoA) and submitted to further downstream metabolism. Two different 
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mechanism are considered for cellular fatty acid uptake: 1) passive diffusion 
2) protein mediated uptake (Abumrad et al., 1998; Hamilton et al., 2002). At a high 
fatty acid to albumin ratio passive diffusion is described to be the predominant 
mechanism whereas at low fatty acid to albumin ratios a facilitated and saturable 
uptake by specialized proteins is suggested (reviewed by (Abumrad et al., 1999)). 
Different models and candidate proteins have been discussed in the context of 
cellular fatty acid uptake so far. Black and DiRusso argued for vectorial acylation, 
linking the fatty acid transport across the plasma membrane to intracellular fatty acid 
activation. Thereby, fatty acids would be trapped inside the cells, thus rendering the 
uptake process unidirectional (Black and DiRusso, 2003). For vectorial acylation, a 
functional and spatial coupling at the plasma membrane of a fatty acid transporter 
with a fatty acid activating enzyme is suggested (Zou et al., 2003; Kampf and 
Kleinfeld, 2007) whereas another model argues for metabolic trapping of fatty acids 
at intracellular organelles rather than at the plasma membrane. Within this model, 
intracellular acyl-CoA synthetases would be sufficient to drive fatty acid uptake 
metabolically: fatty acid activation would imbalance the equilibrium of intracellular 
and extracellular free fatty acids and result in a driving force for fatty acid uptake 
(Fullekrug et al., 2012).  
There are three likely candidates for protein mediated cellular fatty acid uptake: fatty 
acid translocase (FAT)/cluster of differentiation 36 (CD36), the family of fatty acid 
transport proteins (FATPs) as well as plasma membrane fatty acid binding protein 
(FABPPM). CD36, an integral transmembrane protein, is highly expressed in adipose 
tissue, heart, skeletal muscle and intestine (reviewed by (Abumrad et al., 1999)). 
Alterations in fatty acid metabolism influence CD36 expression, corresponding to a 
suggested function in fatty acid uptake. Caveolin-1 (Cav-1), a structural protein, has 
been proposed as possible interaction partner for CD36 in mediating fatty acid 
uptake. A whole family of conserved proteins, the FATPs, are equally considered as 
mediators of fatty acid uptake. Two different functions have been proposed for 
FATPs (reviewed by (Gimeno, 2007)), implying that they possess an acyl-CoA 
synthetase activity: direct transport of fatty acids across the cell membrane versus 
intracellular esterification of fatty acids. FABPs bind long-chain fatty acids and are 
suggested to have tissue-specific functions. For plasma membrane fatty acid binding 
protein (FABPpm) various evidence has been obtained for a potential involvement in 
fatty acid metabolism. Changes in fatty acid transport conditions were accompanied 
Introduction 
 8 
by alterations in FABPpm expression levels, including the differentiation of 3T3-L1 
fibroblasts into adipocytes which went along with a rise in fatty acid uptake as well 
as an induction of FABPpm (reviewed by (Brinkmann et al., 2002)). An antibody 
directed against FABPPM inhibited oleate uptake in the hepatocytes (Stremmel et al., 
1986), indicating a role for FABPPM in liver fatty acid uptake.  
A potential interplay of plasma membrane proteins and intracellular proteins has 
been suggested, thus making fatty acid uptake a highly coordinated, multistep 
process. A possible model would implicate the mediation of fatty acid uptake by 
CD36, maybe in interaction with Cav-1. Fatty acids could then be transported by 
FABPs to various organelles for activation by intracellular proteins such as FATP4 
and long-chain acyl-CoA synthetase 1 (ACSL1) (Figure 1).  
 
 
Figure 1: Model of fatty acid uptake. 
CD36 is localized in the plasma membrane where it mediates the uptake of extracellular fatty acids 
into the cell, possibly in cooperation with Cav-1. FABPs transport the fatty acids to intracellular 
organelles like the ER or mitochondria, followed by fatty acid activation by intracellular enzyme such 
as FATP4 and ACSL1 (adapted from (Ehehalt et al., 2006). 
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3.2 Fatty acid translocase CD36  
3.2.1 Structur and function of CD36 
The fatty acid translocase (FAT) or cluster of differentiation 36 (CD36), is an 
integral transmembrane glycoprotein with a molecular weight of 88 kDa. The protein 
is expressed on a variety of different cell types, including adipocytes, hepatocytes, 
myocytes, platelets, mononuclear phagocytes and some epithelia (reviewed by 
(Silverstein and Febbraio, 2009)). In line with its extensive expression pattern, CD36 
has been described to contain multiple functions within the mammalian organism, 
ranging from its action as a pattern recognition receptor over taste perception for fat 
and involvement in inflammatory responses to the uptake of long-chain fatty acids. 
CD36 represents a gene family together with two other proteins, lysosomal integral 
membrane protein-2 (LIMP-2) as well as CD36 and LIMP-2 analogous (CLA-1), 
equally named scavenger receptor B-1 (SRB-1). Orthologs of CD36 were identified 
in insects, nematodes, sponges and slime mold, thereby indicating that the common 
ancestral gene dates back more than 300 million years.  
The protein structure is conserved in mammals and characterized by a prominent 
extracellular domain ending in two short cytoplasmic tails. The extracellular loop is 
heavily glycosylated and features three disulfide bonds at conserved cysteines 
(Cys243- Cys311, Cys272-Cys333, and Cys313-Cys322) together with at least two 
ligand binding domains, one for proteins with thrombospondin repeat (TSR) domain 
and one for oxidized lipids. The C- and the N-terminal part are located intracellularly 
and contain two palmitoylated cysteine residues each (reviewed by (Silverstein and 
Febbraio, 2009), Figure 2). The C-terminal part of CD36 was shown to be required 
for proper localization at the cell surface, as a truncation of the final 10 amino acids 
caused intracellular retention of the protein (Eyre et al., 2007). Furthermore, 
inhibition of cysteine palmitoylation interfered with CD36 processing at the 
endoplasmic reticulum as well as with trafficking through secretory pathways, 
indicating a regulatory function for palmitoylation in the translocation of CD36 to 
the plasma membrane (Thorne et al., 2010). Although CD36 has been investigated 
for decades, only little light has been shed on its intracellular signaling so far. 
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Figure 2: Structure of CD36 
The transmembrane protein CD36 is characterized by a prominent extracelluar loop that is heavily 
glyosylated. The C- and N-terminus are short, intracellularly located tails that each feature two 
palmitoylated cysteines. The extracellular part of the protein contains three disulfid bonds linking 
conserved cysteine residues as well as ligand binding domains for proteins with TSR domain and 
oxidized lipids (adapted from (Silverstein and Febbraio, 2009)). 
 
Suggestions have been made as to linking CD36 signaling to the activation of Src 
kinases and nitric-oxide synthase (reviewed by (Abumrad, 2005)). During lipid 
absorption, CD36 function is regulated by ubiquitination and subsequent degradation 
which is initiated by digestion products (Tran et al., 2011). 
Many publications have so far assigned a role in long-chain fatty acid uptake to the 
CD36 protein (reviewed by (Su and Abumrad, 2009)). CD36 overexpression 
increased oleate uptake in COS cells while the expression of CD36 in the plasma 
membrane was confirmed (Ehehalt et al., 2008). Bonen and co-workers suggested a 
translocation of CD36 from intracellular stores to the sarcolemma upon muscle 
contraction, thereby linking the function of CD36 in fatty acid uptake to its 
localization at the plasma membrane (Bonen et al., 2000). The relevance of CD36 for 
long-chain fatty acid uptake was further confirmed by animal studies: the intestinal 
uptake of very long-chain fatty acids was strongly impaired in CD36 null mice after 
feeding a high fat diet (Drover et al., 2008). Likewise, CD36 null mice displayed a 
reduction in fatty acid uptake in the muscle and adipose tissue (Coburn et al., 2000). 
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In accordance with its relevance for fatty acid uptake CD36 has been implicated in 
the onset and progression of pathologic conditions like obesity, type 2 diabetes, the 
metabolic syndrome and atherosclerosis (Koonen et al., 2007; Love-Gregory et al., 
2008).  
 
3.2.2 Role of caveolin-1 in CD36 signaling 
CD36 function in fatty acid uptake was hypothesized to be influenced by its 
localization within the plasma membrane. The cellular membrane is an 
inhomogeneous structure that is subdivided in liquid ordered and liquid disordered 
domains. Tightly packed subdomains, predominantly consisting of cholesterol and 
sphingolipids, float freely within the liquid disordered phase, thus generating a 
subcompartmentalization which spotlights and coordinates the bioactivity of 
membrane components (Lingwood and Simons, 2010). These so termed lipid rafts 
play an important role as signaling platforms involved in various cellular processes 
by concentrating receptors and signaling molecules in one place.  
Caveolae are a special subset of lipid rafts. They are small cell membrane 
invaginations which are involved in cell signaling and transport processes. They are 
composed of the coat proteins caveolin-1, -2 and -3 (Cav-1, -2, -3), with Cav-1 and 
Cav-3 being essential for proper caveolae construction. Also caveolae do occur in 
different cell types they are most often found in adipocytes as well as in vascular 
endothelial cells, fibroblasts and epithelial cells (reviewed by (Chidlow and Sessa, 
2010)). Cav-1 binds long-chain fatty acids with high affinity and has been suggested 
to play role in lipid traffic (Liu et al., 2002) and to modulate fatty acid transport 
across the plasma membrane (Meshulam et al., 2006).   
When Cav-1 was investigated for its function in fatty acid metabolism, Cav-1 null 
mice developed hyperinsulinemia when nourished with a high fat diet (Cohen et al., 
2003). Another study showed normal serum insulin in Cav-1 null mice but increased 
levels of free fatty acids and triglycerides (Razani et al., 2002) hinting at a role for 
Cav-1 in fatty acid metabolism. 
For CD36, the existence of two pools within the plasma membrane was suggested: 
inside and outside lipid rafts, with raft association leading to an increase in fatty acid 
uptake (Ehehalt et al., 2008). A possible functional relationship of CD36 and Cav-1 
in fatty acid uptake is still a matter of debate. As discussed by Su and Abumrad, 
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caveolin function is regulated by Src kinases which have also been linked to CD36 
signaling (reviewed by (Su and Abumrad, 2009)), indicating a possible interaction. 
Due to the high expression rate of Cav-1 in adipocytes together with the localization 
of CD36 to lipid rafts and its role in fatty acid uptake Cav-1 is a worthwhile target 
for investigation in the context of CD36 function.  
 
3.3 Fatty acid activating enzymes 
3.3.1 The acyl-CoA synthetase family 
Fatty acids need to be activated before they can be used by cells for energy 
production, signaling and further downstream metabolic pathways. The activation of 
fatty acids by esterification with coenzyme A is a highly conserved process that is 
performed in organisms from archea to man (reviewed by (Watkins, 2008)). In 
mammals, this reaction is catalyzed by the family of acyl-CoA synthetases (ACS) 
which can activate fatty acids with various chain lengths, mostly between 12 – 20 
carbon atoms. Depending on their preferred substrates, acyl-CoA synthetase are 
subdivided into short-chain (C2 - C4), medium-chain (C4 – C12), long-chain (C12 – 
C20), very long-chain (C18 – C26) and bubblegum (C14 – C24) acyl-CoA synthetases 
(reviewed by (Soupene and Kuypers, 2008)). There are 26 different acyl-CoA 
synthetases expressed in mammals, including 13 enzymes for the activation of long-
chain fatty acids only. Physiologically of highest importance are the five long-chain 
acyl-CoA synthetases (ACSL1, 3 - 6) as well as the six very long-chain acyl-CoA 
synthetase (ACSVL) or fatty acid transport proteins (FATP1-6), which activate 
intracellular fatty acids including oleate and palmitate.  
Acyl-CoA synthetases play an important role in lipid metabolism and are required to 
ensure lipid homeostasis. The described functions are manifold and include substrate 
provision for energy production and lipid synthesis but also enzyme regulation, 
protein acylation, modulation of ion channels and membrane potential as well as 
protein trafficking (reviewed by (Li et al., 2010)). The localization of the different 
acyl-CoA synthetase family members remains a matter of debate and includes the 
controversy whether the respective proteins are localized at the plasma membrane or 
at intracellular organelles, such as the endoplasmic reticulum, lipid droplets or 
mitochondria.  
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3.3.2 The catalyzed reaction 
The acyl-CoA synthetase family members catalyze the esterification of intracellular 
fatty acids with coenzyme A in order to activate fatty acids for further downstream 
metabolism. During the reaction, an acyl-AMP intermediate is produced under 
consumption of adenosine triphosphate (ATP) (Mashek et al., 2004). In a two-step 
reaction, a thioester bond is formed between the carboxyl group of a fatty acid and 
the sulfhydryl group of coenzyme A. Initially, a fatty acid is converted to an acyl-
adenylate under energy consumption, thereby metabolizing ATP to pyrophosphate. 
In a second step, the sulfhydryl group of coenzyme A reacts with the intermediate 
acyl-adenylate in order to produce acyl-CoA and adenosine monophosphate (AMP) 
(Figure 3). Both reaction steps are completely reversible. The equilibrium of the 
reaction is shifted towards the production of acyl-CoA by fast hydrolysis of the 
intermediate pyrophosphate (Berg JM, 2003).  
.  
 
 
Figure 3: Activation of fatty acids by esterification with coenzyme A. 
Free fatty acids are activated by esterification with coenzyme A in a two-step process. At first, a fatty 
acid reacts with ATP in order to form an acyl-adenylate intermediate under energy consumption. The 
resulting pyrophosphate is rapidly hydrolyzed, thereby driving the reaction. Secondly, coenzyme A is 
bound to the acyl-adenylate by a thioester bond in order to generate acyl-CoA and AMP (adapted 
from (Berg JM, 2003)). 
 
Although its catalyzed reaction has been characterized, the mammalian acyl-CoA 
synthetase structure remains yet to be identified. Homologies to the bacterial isoform 
indicate a similar mode of action for the mammalian version. In bacteria, acyl-CoA 
synthetases act as dimers. Their structure features a conserved fatty acid Gate domain 
which defines substrate specificity (reviewed by (Forneris and Mattevi, 2008; 
Soupene and Kuypers, 2008)). One main obstacle that has to be overcome by acyl-
CoA synthetases is the simultaneous interaction with hydrophilic as well as 
hydrophobic substrates. The bacterial acyl-CoA synthetase FACS is an elegant 
example of how molecules derived from the aqueous cellular environment together 
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with molecules originating from the lipid bilayer can be introduced in a common 
reaction that is catalyzed by one single enzyme. FACS dimers are located close to the 
lipid bilayer from which fatty acid substrates are directly obtained. A hydrophobic 
cavity is formed between the two monomeric parts which binds fatty acids in a 
position that makes the carboxyl group accessible for the hydrophilic substrates. ATP 
and coenzyme A are taken up through a hydrophilic entrance facing the aqueous 
environment. After completing the reaction, the acyl-CoA product is released 
through the hydrophilic opening (Figure 4). In conclusion, by action of the bacterial 
acyl-CoA synthetase FACS a hydrophilic fatty acid has been made accessible to 
cellular metabolic pathways by coupling to hydrophilic coenzyme A (reviewed by 
(Forneris and Mattevi, 2008)). 
 
Figure 4: Mechanism of fatty acid activation by the bacterial acyl-CoA synthetase FACS. 
FACS acts as a dimer which is closely associated with cellular membranes. Hydrophobic fatty acid 
substrates originiate from lipid membranes and are transported to the enzymatically active site through 
a hydrophobic cavity. The hydrophilic substrates ATP and coenzyme A are derived from the aqueous 
environment through a hydrophilic opening. After coupling coenzyme A to the fatty acid the resulting 
hydrophilic product is released via the hydrophilic channel (adapted from (Forneris and Mattevi, 
2008)). 
 
3.3.3 Fatty acid transport protein 4 (FATP4) 
In 1994, the first FATP was identified from a murine adipocyte cDNA library as a 
protein that increased long-chain fatty acid uptake when overexpressed in adipocytes. 
The protein, which was subsequently termed FATP1, showed an increased 
expression during the differentiation of 3T3-L1 adipocytes, corresponding to a 
formerly described rise in long-chain fatty acid uptake (Schaffer and Lodish, 1994). 
In the following years, six human FATPs (FATP1-6) were identified as 
transmembrane proteins with a common, highly conserved FATP signature sequence. 
The different family members are expressed in various cell types, all of which are 
involved in fatty acid metabolism (reviewed by (Stahl et al., 2001)). Although there 
is congruency about the involvement of FATPs in fatty acid uptake, the underlying 
mechanism as well as the subcellular localization are still under debate.  
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The family member FATP4 is expressed in adipose tissue, brain, skeletal muscle, 
heart and intestine. FATP4-null mice display severe skin defects, including 
hyperproliferative hyperkeratosis, defective barrier function and restrictive 
dermopathy. In consequence, animals die before or closely after birth. The epidermis 
of FATP4-null mice is characterized by altered lipid levels, with a decrease in 
phosphatidylcholine, phosphatidylethanolamine and cholesterol ester content, hinting 
at a profound influence of FATP4 on lipid metabolism (reviewed by (Watkins, 
2008)). 
Stahl and co-workers described FATP4 as a plasma membrane localized fatty acid 
transporter, that is expressed on the apical site of enterocytes (Stahl et al., 1999), thus 
facilitating fatty acid uptake. This view was contradicted by studies clearly showing 
an intracellular localization of FATP4 at the endoplasmic reticulum. Although a 
function of FATP4 as fatty acid transporter was thus excluded, a positive correlation 
was shown between protein expression and fatty acid uptake (Milger et al., 2006). In 
accordance with increased FATP4 expression levels, acyl-CoA synthetase activity 
and fatty acid uptake were enhanced in hepatoma cell lines HuH7 and HepG2 
(Krammer et al., 2011) as well as in 3T3-L1 adipocytes (Zhan et al., 2012). FATP4 
mediated fatty acid uptake was further increased by short term insulin treatment, 
hinting at a new target in insulin dependent metabolic modulation (Digel et al., 
2011). These results reverse the view of FATP4 as a plasma membrane located fatty 
acid transport protein. It was rather shown that intracellular activation of fatty acids 
by acyl-CoA synthetases is sufficient to drive cellular fatty acid uptake.   
 
3.3.4 Long-chain acyl-CoA synthetase 1 (ACSL1) 
Mammalian long-chain acyl-CoA synthetases play an important role in lipid 
metabolism by generation of long-chain acyl-CoA esters that have regulatory 
functions. To date, five long-chain acyl-CoA synthetase genes have been identified 
in humans, with each gene having different transcript variants. In 1990, the first 
cDNA encoding an long-chain acyl-CoA synthetase was isolated from rat liver and 
subsequently termed ACSL1. Indications for a relevance in fatty acid metabolism 
were obtained by observation of an increase in ACSL1 mRNA in rat liver after 
feeding a high fat diet (Suzuki et al., 1990).  
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The intracellular localization of long-chain acyl-CoA synthetase proteins is 
controversial as different studies place them either in the plasma membrane or at 
various intracellular locations. ACSL1 has been detected on mitochondria, lipid 
droplets and the plasma membrane (reviewed by (Soupene and Kuypers, 2008)). 
Upon overexpression in primary rat hepatocytes, ACSL1 was found on the 
endoplasmic reticulum and acyl-CoA synthetase activity was increased. Alterations 
in fatty acid metabolism included the enhanced incorporation of oleate into 
diacylglycerol and phospholipids, whereas less oleate was integrated into cholesterol 
esters. It was suggested, that ACSL1 channeled its substrate fatty acids towards 
different metabolic fates depending on enzyme localization and protein interaction 
(Li et al., 2006). Another study localized overexpressed ACSL1 to mitochondria in 
Ptk2 cells. Oleate uptake was enhanced upon ACSL1 overexpression, verifying that 
the intracellular localization of a fatty acid metabolizing enzyme is sufficient to 
increase fatty acid uptake (Milger et al., 2006).  
ACSL1 accounts for 80 % of total acyl-CoA synthetase activity in adipose tissues 
and represents the predominant long-chain acyl-CoA synthetase isoform in the liver. 
Following a specific knock out of ACSL1 in adipose tissue of mice, animals 
displayed significantly decreased rates of fatty acid oxidation. The results hinted at a 
specific function for ACSL1 in directing fatty acids towards ß-oxidation in 
adipocytes (Ellis et al., 2010). Impaired ß-oxidation was also observed in a liver 
specific ACSL1 knock out mouse model together with a decreased acyl-CoA 
synthetase activity and acyl-CoA amount in the liver (Li et al., 2009). Accordingly, 
ACSL1 is involved in regulating lipid metabolism by directing fatty acids towards ß-
oxidation.  
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3.4 Aim of study 
Lipids are essential components of life and have multiple functions in cellular 
metabolism. They contribute to the construction of cellular membranes, serve as 
signaling molecules and are needed for energy storage and supply. Imbalances of 
lipid homeostasis can contribute to onset and progression of diseases like the 
metabolic syndrome, diabetes type 2, atherosclerosis and cardiovascular illnesses. 
Therefore, cellular fatty acid uptake has to be carefully regulated.  
Proteins implicated in fatty acid transport are the gylcoprotein CD36, the acyl-CoA 
synthetases FATP4 and ACSL1 and the structural protein Cav-1. CD36, FATP4 and 
ACSL1 were described to increase cellular fatty acid uptake upon overexpression, 
mediated by different mechanisms. CD36 is a plasma membrane localized protein 
that directly facilitates fatty acid transport whereas FATP4 and ACSL1 are localized 
intracellularly. They indirectly drive fatty acid uptake by depleting the level of 
intracellular fatty acids through fatty acid activation, thus making them available for 
downstream metabolic pathways. Cav-1 is a structural protein of membrane 
invaginations, termed caveolae. It possesses a lipid binding site and has been linked 
to mediating intra- and extracellular lipid transport. 
CD36, FATP4 and ACSL1 localization and their function in fatty acid uptake have 
been a topic of interest for several years. But to date, no analysis was performed in 
which the amounts of overexpressed proteins were quantified and then related  to 
their specific effect on fatty acid uptake. Accordingly, this study addressed two main 
topics: 
 
1) the molecular stoichiometry of fatty acid uptake 
 absolute quantification of CD36, FATP4 and ACSL1 protein amounts in 
overexpressing cell lines 
 calculation of protein-specific fatty acid uptake by relating protein quantities 
to the respective increase in oleate uptake  
 
2) the potential cooperativity of proteins regulating fatty acid uptake 
 investigation of whether CD36, FATP4 and ACSL1 cooperate in facilitating 
fatty acid uptake  
 analysis of the influence of Cav-1 on CD36 mediated fatty acid transport 
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MDCK cells were chosen as a model system because they are not specialized in lipid 
transport, unlike adipocytes, muscle cells or cardiac cells, and thus permitted an 
unbiased quantitiative analysis. For experiments, it was required to generate MDCK 
cells with stable protein overexpression (FATP4, ACSL1) or knock down (Cav-1) as 
well as MDCK cells with adjustable protein overexpression (CD36 or FATP4 
adenovirus infected cells).  
Absolute protein amounts of CD36, FATP4 and ACSL1 should be quantified by 
western blotting and calculated by densitometric analysis by comparison to a 
recombinant protein standard. Cells should be incubated with ³H-oleic acid for 3 h 
and fatty acid uptake should be determined by radiolabeled measurement. Finally, 
the specific alteration in fatty acid uptake should be calculated for the assessed 
amount of overexpressed protein. Cellular localization as described in the scientific 
literature should be verified for each protein by immunofluorescene.  
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4. Material and Methods 
If not otherwise noted disposable and non-disposable materials were manufactured 
by Eppendorf (Hamburg), Greiner Bio-One (Frickenhausen) and Schott (Mainz). 
Chemicals were purchased from the Chemikalienlager Zentralbereich Neuenheimer 
Feld 367 (Heidelberg), AppliChem (Darmstadt), Merck (Darmstadt), Carl Roth 
(Karlsruhe) and Sigma-Aldrich (Steinheim).  
 
4.1 Equipment 
4.1.1 Molecular biology equipment 
Table 1: Molecular biology equipment used in this study.  
equipment manufacturer 
agarose gel chamber cti, Idstein 
agarose gel documentation system  Peqlab, Erlangen 
BioPhotometer Eppendorf, Hamburg 
centrifuges 
refrigerated bench-top centrifuge 5804 R 
rotors: A 4-44, F 34-6-38  
refrigerated microcentrifuge 5415 R  
rotor: F 45-24-11  
ultracentrifuge Optima XL-90  
Rotor: SW 41-Ti 
 
Eppendorf, Hamburg 
 
Eppendorf, Hamburg  
 
Beckman Coulter, Krefeld 
 
Electroporator Gene Pulser Xcell Bio-Rad, München 
electroporation cuvettes Peqlab, Erlangen 
GeneAmp PCR System 2400 Perkin Elmer, Waltham (USA) 
microplate reader PHOmo Anthos Mikrosysteme, Krefeld 
microscopes 
fluorescence microscope BX41  
laser scanning spectral confocal microscope TCS SP2 
 
Olympus, Hamburg  
Leica, Wetzlar 
pH meter SevenEasy   Mettler-Toledo, Schwerzenbach (Schweiz) 
polyclear tubes for ultracentrifugation  
(14 mm x 89 mm) Beranek, Weinheim 
 
 
Material and Methods 
 20 
4.1.2 Protein biochemistry equipment 
Table 2: Protein biochemistry equipment used in this study.  
equipment manufacturer 
Amersham Hyperfilm ECL  GE Healthcare, München 
autoradiography hypercassette Amersham Biosciences, Little Chalfont (UK) 
blotting paper  Schleicher und Schüll/Whatman, Dassel  
developer machine Agfa Curix 60  Christiansen, München 
Protran nitrocellulose membrane  Whatman, Dassel 
sodium dodecyl sulfate polyacrylamide                
gel electrophoresis (SDS-PAGE) chamber  Bio-Rad, München 
semi-dry blotting chamber cti, Idstein 
 
4.1.3 Radioactive work equipment 
Table 3: Radioactive work equipment used in this study.  
equipment manufacturer 
liquid scintillation counter LS 6500  Beckman Coulter, Krefeld 
polyethylene vials for liquid scintillation counting      
Minis 2000 Zinsser Analytic, Frankfurt am Main 
Safe-Lock tubes (1.5 ml)  Eppendorf, Hamburg 
Ultima Gold  Perkin Elmer, Waltham (USA) 
 
4.1.4 Cell culture equipment  
Table 4: Cell culture equipment used in this study. 
equipment manufacturer 
cell culture dishes (60 cm2, 145 cm2)   Cellstar/Greiner Bio-One, Frickenhausen 
cell culture flasks (T25, T75, T175)  Cellstar/Greiner Bio-One, Frickenhausen 
cell culture multiwell plates (6-well, 12-well, 96-well)  Cellstar/Greiner Bio-One, Frickenhausen 
cover slips (10 mm in diameter)  Marienfeld, Lauda-Königshofen 
Microscope slides  Marienfeld, Lauda-Königshofen 
Neubauer improved counting chamber Assistent, Sondheim/Rhön 
sterile syringe filters, nitrocellulose free (0.45 µm) Millipore, Schwalbach/Ts   
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4.2 Chemicals 
4.2.1 Molecular biology chemicals 
Table 5: Molecular biology chemicals used in this study.  
chemical manufacturer 
bovine serum albumin (BSA) (A6003) Sigma-Aldrich, Steinheim 
fatty acid free BSA (A3803) Sigma-Aldrich, Steinheim 
6 x DNA Loading Dye Fermentas, St. Leon-Rot 
Deoxyribonucleoside triphosphate (dNTP) mix (10 mM each) Fermentas, St. Leon-Rot 
Kanamycin Sigma-Aldrich, Steinheim 
 
4.2.2 Protein biochemistry chemicals 
Table 6: Protein biochemistry chemicals used in this study. 
chemical manufacturer 
acrylamide/bis solution (30 %) Bio-Rad, München 
ammonium persulfate (APS)   Sigma-Aldrich, Steinheim 
ANTI-FLAG M2 affinity gel  Sigma-Aldrich, Steinheim 
ß-mercaptoethanol  AppliChem, Darmstadt 
blotting grade blocker nonfat dry milk  Bio-Rad, München 
Bradford protein assay dye   Bio-Rad, München 
bromphenolblue Merck, Darmstadt 
Coomassie brilliant blue R-250 Merck, Darmstadt 
FATP4FLAG protein standard 
S. Staudacher, AG J. Füllekrug,  
University Hospital Heidelberg 
N,N,N',N'-tetramethylethylenediamine (TEMED) AppliChem, Darmstadt 
Ponceau Red  Serva Electrophoresis, Heidelberg 
sodium dodecyl sulfate (SDS) Sigma-Aldrich, Steinheim 
Western Lightning Plus enhanced chemiluminescence (ECL)  Perkin Elmer, Waltham (USA) 
 
4.2.3 Radioactive work chemicals 
Table 7: Radioactive work chemicals used in this study. 
chemical manufacturer 
oleic acid  Sigma-Aldrich, Steinheim 
³H-oleic acid  Perkin Elmer, Waltham (USA) 
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4.2.4 Cell culture chemicals 
Table 8: Cell culture chemicals used in this study. 
chemical manufacturer 
ampicillin sodium salt  Sigma-Aldrich, Steinheim  
calcium chloride (CaCl2) Sigma-Aldrich, Steinheim 
cesium chloride (CsCl)  Boehringer-Mannheim, Mannheim 
Collagen R solution   Serva, Heidelberg 
culture medium DMEM/MEM/OptiMEM  Gibco/Invitrogen, Carlsbad (USA) 
dimethyl sulfoxide (DMSO)   Sigma-Aldrich, Steinheim 
fetal bovine serum (FBS)  Gibco/Invitrogen, Carlsbad (USA) 
GlutaMAX-I (200 mM, 100 x) Gibco/Invitrogen, Carlsbad (USA) 
Hoechst 33342 Invitrogen, Carlsbad (USA)  
Lipofectamine 2000   Invitrogen, Carlsbad (USA) 
Mowiol mounting medium   Calbiochem, La Jolla (USA) 
paraformaldehyde (PFA)  Riedel-de Haën, Seelze 
penicillin (10 U/µl)/streptomycin (10 g/l)  Gibco/Invitrogen, Carlsbad (USA) 
Polybrene (hexadimethrine bromide)   Sigma-Aldrich, Steinheim 
Puromycin  Clontech, Mountain View (USA) 
Saponin Quillaja Bark Sigma-Aldrich, Steinheim 
Teleostan gelatin   Sigma-Aldrich, Steinheim 
trypsin  Gibco/Invitrogen, Carlsbad (USA) 
 
4.3 Kits  
Table 9: Kits used in this study. 
kit manufacturer 
Marligen PowerPrep® HP Plasmid Purification System     OriGene, Rockville (USA) 
Nucleo Spin® Extract Kit II    Macherey-Nagel, Düren 
Nucleo Spin® Plasmid Kit   Macherey-Nagel, Düren 
QIAquick Gel Extraction Kit   Qiagen, Hilden     
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4.4 Molecular biology material 
4.4.1 Molecular weight standards 
Table 10: Molecular weight standards used in this study. 
weight standard range manufacturer 
GeneRuler™ 1 kilobase (kb) DNA Ladder  250-10,000 base pairs (bp) Fermentas, St. Leon-Rot 
Page RulerTM Prestained Protein Ladder   10-170 kilodalton (kDa) Fermentas, St. Leon-Rot 
 
4.4.2 Antibodies 
Table 11: Antibodies used in this study. 
incubation conditions 
antibody 
WB IF 
characteristics manufacturer 
primary antibodies 
ms-α- 
β-actin 
1:200,000 
(over night, 4 °C) - monoclonal antibody 
A5441  
Sigma-Aldrich, Steinheim 
ms-α-CD36 - 1:200  (1 h, RT) 
monoclonal antibody, 
raised against human 
CD36 
sc-70642 
Santa Cruz Biotechnology 
Heidelberg 
ms-α-
FLAG M2 - 
1:1,000 
(1 h, RT) 
monoclonal antibody, 
affinity purified 
F1804 
Sigma-Aldrich, Steinheim 
rb-α-Cav1 
(N20) 
1:20,000 
(1 h, RT) 
1:200 
(1 h, RT) 
polyclonal antibody, 
affinity purified, 
raised against human 
Cav-1 
sc-894  
Santa Cruz Biotechnology 
Heidelberg 
rb-α-
FATP4 
(C3/5) 
1:5,000  
(over night, 4 °C) 
1:1,000  
(1 h, RT) - 
J. Füllekrug, University 
Hospital Heidelberg     
(Milger et al., 2006) 
rb-α-FLAG 1:10,000 (over night, 4 °C) 
1:500 
(1 h, RT) 
polyclonal antibody, 
affinity purified 
F7425 
Sigma-Aldrich, Steinheim 
secondary antibodies 
α-ms-Cy2 - 1:200 (1 h, RT) 
Cy2-conjugated  
anti-mouse IgG 
715-225-151  
Dianova, Hamburg 
α-ms-Cy3 - 1:1,000 (1 h, RT) 
Cy3-conjugated  
anti-mouse IgG 
715-165-151  
Dianova, Hamburg 
α-rb-Cy2 - 1:200 (1 h, RT) 
Cy2-conjugated  
anti-rabbit IgG 
711-225-152 
Dianova, Hamburg 
α-rb-Cy3 - 1:1,000 (1 h, RT) 
Cy3-conjugated  
anti-rabbit IgG 
711-165-152 
Dianova, Hamburg 
α-ms-HRP 1:10,000 (1 h, RT) - 
peroxidase-conjugated 
anti-mouse IgG 
711-035-003 
Dianova, Hamburg 
α-rb-HRP 1:10,000 (1 h, RT) - 
peroxidase-conjugated 
anti-rabbit IgG 
711-035-152 
Dianova, Hamburg 
western blot (WB), immunofluorescence (IF), mouse (ms), rabbit (rb), anti (α), room temperature 
(RT), horseradish peroxidase (HRP), immunoglobulin G (IgG) 
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4.4.3 Enzymes 
Table 12: Enzymes used in this study. 
enzyme activity [units (U)/ml] manufacturer 
general enzymes 
Antarctic Phosphatase - New England Biolabs, Frankfurt am Main 
Quick T4 DNA Ligase - New England Biolabs, Frankfurt am Main 
thermus aquaticus (taq) 
DNA Polymerase - Qiagen, Hilden 
restriction enzymes 
AgeI    5,000 U/ml  New England Biolabs, Frankfurt am Main 
BglII  10,000 U/ml  New England Biolabs, Frankfurt am Main 
KpnI  10,000 U/ml  Fermentas, St. Leon-Rot 
NdeI  20,000 U/ml  New England Biolabs, Frankfurt am Main 
PacI 10,000 U/ml  New England Biolabs, Frankfurt am Main 
PmeI  10,000 U/ml New England Biolabs, Frankfurt am Main 
XbaI  20,000 U/ml  New England Biolabs, Frankfurt am Main 
XhoI  20,000 U/ml  New England Biolabs, Frankfurt am Main 
 
4.4.4 Oligonucleotides 
Oligonucleotides were purchased from Sigma-Aldrich (Steinheim) and adjusted to a 
working concentration of 100 µM in sterile H2O.  
 
Table 13: Oligonucleotides used in this study. 
primer Tm  length sequence (5` - 3`) 
s_CD36-1_LC   65.7 °C 21 TTGATGTGCAAAATCCACAGG 
s_CD36-2_LC 65.1 °C 19 AAAACGGCTGCAGGTCAAC 
a_CD36-2_LC 65.0 °C 20 TCACCAATGGTCCCAGTCTC 
s_CD36.FLAG 
(adeno) 79.7 °C 33 GGTACCAGATCTACCATGGGCTGTGACCGGAAC 
a_CD36.FLAG 
(adeno) 74.1 °C 31 AAGCTTCTCGAGTTACTTGTCATCGTCGTCC 
CMV forward 76.8 °C 21 CGCAAATGGGCGGTAGGCGTG 
EGFP-C 62.0 °C 20 ATGGTCCTGCTGGAGTTCGT 
antisense (a_), sense (s_), melting temperature (Tm), green fluorescent protein (GFP) 
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4.4.5 Plasmids 
Table 14: Plasmids for cloning used in this study. 
plasmid characteristics tag resistence reference internal 
number 
plasmids for cloning 
pcDNA3 mammalian expression 
vector - 
ampicillin, 
neomycin 
Stratagene,  
Santa Clara 
(USA) 
JF 001 
GFP 
-CD36. pNice 
plasmid for subcloning, 
ligation of GFP-
CD36FLAG into pEGFP-
N1, green fluorescence 
FLAG kanamycin this work JF 782 
GFP 
-CD36-FLAG 
expression vector for 
human CD36 with N-
terminal GFP and C-
terminal FLAG, green 
fluorescence   
FLAG kanamycin, 
neomycin 
D.  Lublin,  
St. Louis  
(USA) 
JF 664 
pEGFP-N1 enhanced green fluores-
cent protein expression  - 
kanamycin, 
neomycin 
Clontech,  
Mountain View 
(USA) 
JF 067 
 
CD36-
FLAG.pcDNA3 
expression vector for 
human CD36 with C-
terminal FLAG 
FLAG ampicillin, 
neomycin 
D.  Lublin,  
St. Louis  
(USA) 
JF 502 
 
 
Table 15: Retroviral plasmids used in this study. 
plasmid characteristics tag resistence reference internal 
number 
retroviral plasmids 
pQCXIP-J (pQ) 
retroviral expression 
vector, based on 
pQCXIP (BD Bio-
sciences, Clontech, 
Heidelberg) 
- 
ampicillin, 
puromycin 
J. Füllekrug, 
University Hos-
pital Heidelberg 
JF 596 
 
cav1-
ko.pRVH1puro 
retroviral expression 
vector for stable Cav-1 
knock down by RNA 
interference  
- 
ampicillin, 
puromycin 
MPI-CBG, 
Dresden 
(Schuck et al., 
2004) 
JF 383 
 
ACSL1.pRJ 
retroviral expression 
vector for stable 
overexpression of rat 
ACSL1 with C-terminal 
FLAG 
FLAG ampicillin, puromycin 
T. Zhan,  
AG    J. Füllekrug, 
University Hos-
pital Heidelberg 
JF 659 
 
pVSV-G 
expression vector for the 
Vesicular Stomatitis 
Virus glycoprotein 
- ampicillin 
MPI-CBG, 
Dresden  
(Schuck et al., 
2004) 
JF 380 
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Table 16: Adenoviral plasmids used in this study. 
plasmid characteristics tag resistence reference internal 
number 
adenoviral plasmids 
pAda/pshuttle-
CMV 
basic transfer plasmid 
for recombinant adeno-
virus construction 
- kanamycin 
P. Keller,  
MPI-CBG, 
Dresden 
JF 101 
CD36.pAda 
adenoviral shuttle 
plasmid for human 
CD36 with C-terminal 
FLAG 
FLAG ampicillin this work JF 780 
GFP 
-CD36.pAda 
adenoviral shuttle 
plasmid for human 
CD36 with N-terminal 
GFP and C-terminal 
FLAG, green fluores-
cence 
FLAG ampicillin this work JF 781
  
FATP4. 
pAdTrack-
CMV 
adenoviral expression 
plasmid for murine 
FATP4, cytosolic green 
fluorescence 
- kanamycin 
C. Becker,  
AG J. Füllekrug, 
University Hos-
pital Heidelberg 
JF 430 
pAdEasy-1 
adenoviral backbone 
plasmid with E1/E3 
deletion for recombinant 
adenovirus contruction                
- kanamycin 
P. Keller,  
MPI-CBG, 
Dresden 
JF 109 
 
CD36.pAdv 
adenoviral expression 
plasmid for human 
CD36 with C-terminal 
FLAG  
FLAG ampicillin this work JF 790 
GFP 
-CD36.pAdv 
adenoviral expression 
plasmid for human 
CD36 with N-terminal 
GFP and C-terminal 
FLAG, green fluores-
cence     
FLAG ampicillin this work JF 791 
 
4.5 Buffers and media 
4.5.1 Media 
Luria Bertani (LB) media for cultivation of bacteria were autoclaved before use. Cell 
culture media and supplements were sterile at delivery and subsequently handled 
under sterile conditions.  
 
Table 17: Media used in this study. 
medium components purpose 
molecular biology 
LB medium 
10 g/l tryptone, 5 g/l yeast extract, 10 g/l 
NaCl, pH 7.0, for plates: 30 g Select agar/l 
(100 µg/ml ampicillin, 30 µg/ml kanamycin) 
E. coli 
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cell culture 
DMEM 
DMEM 4.5 g/l glucose + GlutaMAX 
+ 10 % (v/v) FBS 
+ 1 % (v/v) pen/strep 
HEK 239 cells 
phoenix gp cells 
DMEM low glucose DMEM 1 g/l glucose + GlutaMAX 
+ 10 % (v/v) FBS retrovirus production 
MEM 
MEM 4.5 g/l glucose + GlutaMAX 
+ 10 % (v/v) FBS 
+ 1 % (v/v) pen/strep 
MDCK cells 
OptiMEM reduced serum medium adenoviral infection lipofection 
Dulbecco’s modified Eagle’s medium (DMEM), Eagle’s minimum essential medium (MEM) 
 
4.5.2 Buffers 
If not otherwise stated buffers were prepared in Millipore-H2O. The appropriate pH 
was adjusted at room temperature whenever required.    
 
Table 18: Buffers used in this study. 
buffer components 
molecular biology 
6 x DNA loading dye 38 % (w/v) glycerol, 0.08 % (w/v) bromphenolblue, 0.08 % (w/v) 
xylencyanol 
Inoue Transformation 
Buffer (ITB)  
10 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) (pH 6.7 with 
KOH), 15 mM CaCl2, 250 mM KCl, 55 mM MnCl2 
phosphate buffered 
saline (PBS) 137 mM NaCl, 10 mM Na2HPO4, 2.7 mM KCl, 2 mM KH2PO4, pH 7.4 
2 x adenovirus storage 
buffer 
10 mM tris(hydroxymethyl)aminomethane (Tris) (pH 8.0), 100 mM 
NaCl, 0.1 % (w/v) BSA, 50 % (w/v) glycerol 
10 x Tris acetate EDTA 
(TAE) 
400 mM Tris/acetate, 10 mM ethylenediaminetetraacetic acid 
(EDTA)/NaOH,   pH 8.0 
western blot 
blotting buffer 25 mM Tris, 190 mM glycin, 20 % (v/v) MeOH 
0.1 % coomassie blue  1 g Coomassie brilliant blue R-250, 300 ml MeOH, 200 ml H2O, dissolved at RT, 400 ml H2O, 100 ml (glacial) acetic acid 
destain solution 10 % (v/v) acetic acid, 30 % (v/v) MeOH 
4 x Laemmli buffer 250 mM Tris/HCl (pH 6.8), 50 % (w/v) glycerol , 8 % (w/v) SDS, 0.02 % (w/v) bromphenolblue, 5 % (v/v) β-mercaptoethanol 
running buffer 25 mM Tris, 190 mM glycin, 0.1 % (w/v) SDS 
SDS-PAGE special 
 sample buffer 62 mM Tris/HCl (pH 6.8), 2 % (w/v) SDS, 10 % (w/v) glycerol 
20 x Tris buffered 
saline (TBS) Tween 200 mM Tris/HCl, 3 M NaCl (pH 7.4), 2 % (v/v) Tween-20 
Tris NaCl EDTA 
(TNE) buffer 150 mM NaCl, 20 mM Tris/HCl (pH 7.4), 1 mM EDTA 
Tris NaCl EDTA Tri- 
ton X (TNEX) buffer 
150 mM NaCl, 20 mM Tris/HCl (pH 7.4), 1 mM EDTA, 0.2 % (v/v) 
Triton X-100 
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radioactive assay 
STOP-mix 0.5 % (w/v) BSA with fatty acids in 1x PBS 
cell culture  
2 x HEPES buffered 
saline (HBS)  
280 mM NaCl, 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), 12 mM glucose, 10 mM KCl, 1.5 mM Na2HPO4, pH 6.95 
immunofluorescence  
Mowiol pH 8,5 
4.8 g Mowiol, 12 g glycerol, 12 ml H2O, dissolve at RT, 24 ml 0.2 M 
Tris/HCl (pH 8.5), dissolve at < 50 °C, centrifugation at 5,000 g for 15 
min, use supernatant 
4 % PFA 40 g PFA dissolved in 1 l 1 x PBS at < 80°C, 100 µl 1 M CaCl2, 100 µl 1 M MgCl2, pH 7.4 
saponin gelatine (SG) 
washing solution 
0.01 % (w/v) saponin, 0.2 % (w/v) gelatin, 0.02 % (v/v) sodium azide, in 
1 x PBS 
saponin gelatine BSA 
(SGB) washing/ 
blocking solution 
0.1 % (w/v) saponin, 0.5 % (w/v) gelatin, 5 mg/ml BSA, 0.02 % (v/v)          
sodium azide, in 1 x PBS 
 
 
4.6 Cells, viruses, bacteria 
4.6.1 Cells 
All cell lines were maintained under sterile conditions at 37 °C and 5 % CO2. Stocks 
were stored in liquid nitrogen.  
 
Table 19: Cells used in this study.  
cell line characteristics ATCC reference medium passaging 
for assays 
wt MDCK canine kidney 
cells  
CCL-
34 MPI-CBG, Dresden MEM  
at post-confluency, 
1/2 for assays,  
1/8 for propagation 
ACSL1FLAG 
MDCK 
canine kidney 
cells stably 
overexpressing rat 
ACSL1FLAG  
- this work MEM  
at post-confluency, 
1/2 for assays,  
1/8 for propagation 
Cav-1 KD 
MDCK 
canine kidney 
cells with stable 
Cav-1 knock 
down 
- this work MEM  
at post-confluency, 
1/2 for assays,  
1/8 for propagation 
FATP4 
MDCK 
canine kidney 
cells stably over-
expressing  mouse 
FATP4 
- 
M. Poppelreuther 
AG J. Füllekrug, 
University Hospital 
Heidelberg 
MEM  
at post-confluency, 
1/2 for assays,  
1/8 for propagation 
pQCXIP-J 
MDCK 
canine kidney 
cells stably infec-
ted with a retro-
viral expression 
plasmid 
- this work MEM  
at post-confluency, 
1/2 for assays,  
1/8 for propagation 
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for protein standards 
FATP4FLAG 
MDCK  
canine kidney 
cells stably over-
expressing mouse 
FATP4FLAG 
- 
M. Poppelreuther, 
AG J. Füllekrug, 
University Hospital 
Heidelberg 
MEM  at post-confluency, 1/8 for propagation 
FLAGFATP4 
MDCK  
canine kidney 
cells stably over-
expressing shor-
tened human   
FLAG FATP4 
- 
S. Staudacher,  
AG J. Füllekrug, 
University Hospital 
Heidelberg 
MEM  at post-confluency, 1/8 for propagation 
for retrovirus production 
Phoenix gp 
gag pol expres-
sing human 
embryonic kid-
ney cells 
SD-
3514 MPI-CBG, Dresden DMEM 
at sub-confluency,  
1/6 for propagation 
for adenovirus production 
Hek293  
human embry-
onic kidney cells 
containing ade-
novirus 5 DNA 
CRL-
1573 MPI-CBG, Dresden DMEM 
at sub-confluency,  
1/6 for propagation 
human embryonic kidney (HEK), Madin-Darby canine kidney (MDCK) 
 
4.6.2 Viruses 
Retroviral stocks were kept frozen at -80 °C. Adenoviruses were stored in 50 % 
storage buffer at -20 °C. 
 
Table 20: Viruses used in this study.  
virus characteristics based on  reference 
retroviruses 
ACSL1FLAG 
retroviral rat ACSL1FLAG 
overexpression 
ACSL1.pRJ  
(JF 659) this work 
Cav-1 Cav-1 knock down by RNA interference 
cav1-ko.pRVH1 puro 
(JF 383) this work 
pQCXIP-J 
generated from retroviral 
expression vector (used as 
control in retroviral infection) 
pQCXIP-J  
(JF 596) this work 
adenoviruses 
CD36FLAG 
adenoviral human CD36FLAG 
overexpression 
CD36.pAdv  
(JF 790) this work 
FATP4 
adenoviral murine FATP4 
overexpression, cytosolic GFP 
expression 
FATP4.pAdTrack-CMV 
(JF 430) 
J. Füllekrug, 
University Hospital 
Heidelberg/this work 
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4.6.3 Bacteria 
For propagation and cloning procedures Escherichia coli (E. coli) bacteria were 
cultured in liquid LB medium or on LB plates at 37 °C. Antibiotics were added at a 
concentration of 100 µg/ml for ampicillin and 30 µg/ml for kanamycin for selection 
purposes.  
 
Table 21: Bacteria used in this study.  
strain characteristics/genotype reference 
Dam- and Dcm-methylation positive bacterial cells 
for standard cloning procedures, high yield and purity 
of produced plasmid DNA Escherichia coli 
 DH5α fhuA2 ∆(argF-lacZ)U169 phoA glnV44 Φ80 
∆(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
Invitrogen,  
Frankfurt am Main 
Dam- and Dcm-methylation negative bacterial cells, 
used in cloning procedures with Dam/Dcm-sensitive 
restriction enzymes Escherichia coli  
K12 ER2925 ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 
galT22 mcrA dcm-6 hisG4 rfbD1 
R(zgb210::Tn10)TetS endA1 rpsL136 dam13::Tn9 
xylA-5 mtl-1 thi-1 mcrB1 hsdR2 
New England Biolabs,  
Frankfurt am Main 
streptomycin and ampicillin resistant electroporation 
competent bacterial cells, predestined for 
homologous recombination events aiming at the 
generation of adenoviral expression plasmids 
Escherichia coli  
BJ5183-AD-1 
endA1 sbcBC recBC galK met thi-1 bioT hsdR (Strr) 
[pAdEasy-1 (Ampr)] 
Stratagene/Agilent 
Technologies, 
Waldbronn 
 
4.7 Software  
Table 22: Software used in this study.  
software reference 
Adobe Photoshop 6.0.1 Adobe Systems Incorporated (USA) 
AUTOsoft version 2.3.2 Autobio Co. LTD, Zhengzhou (China) 
BioEdit version 5.0.9 Tom Hall, Ibis Biosciences, Carlsbad (USA) http://www.mbio.ncsu.edu/BioEdit/bioedit.html 
cell^D 2.5 Olympus, Hamburg 
Clone Manager 5.01 Scientific & Educational Software, Cary (USA) 
ClustalW2 European Bioinformatics Institute, Cambridge (UK)  http://www.ebi.ac.uk/Tools/msa/clustalw2/ 
EndNote X2 Thomson Reuters Corporation, New York (USA) 
ImageJ 1.45s Wayne Rasband, National Institutes of Health, Bethesda (USA) http://imagej.nih.gov/ij  
Inkscape 0.48 Inkscape Community http://inkscape.org/ 
Leica Confocal Software LCS Lite Leica, Wetzlar 
Microsoft® Office Excel 2003 SP3 Microsoft Corporation, Redmond (USA) 
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4.8 Molecular biology techniques 
4.8.1 Preparation of chemically competent E. coli 
One commonly used method in molecular biology is the amplification of plasmid 
DNA by its introduction and subsequent expression in bacteria. Typically, competent 
E. coli are used due to their increased susceptibility to the uptake of exogenous 
DNA. There are two kinds of competent E. coli present that are either suitable for 
heat shock transformation (chemically competent cells) or electroporation 
(electrocompetent cells). Most often, E. coli DH5α are employed as the standard 
bacterial strain as they give a high yield and purity of plasmid DNA. In case of 
cloning procedures including the use of Dam/Dcm-sensitive restriction enzymes 
E. coli K12 ER2925 can be used alternatively. The following protocol for the 
preparation of chemically competent E. coli is based on the publication of Inoue et 
al. (Inoue et al., 1990).   
Chemically competent E. coli DH5α were plated on a LB plate without antibiotics 
and grown at 37 °C over night. The following day, a pre-culture was inoculated from 
a single colony in 50 ml LB without antibiotics and incubated at 37 °C and 
230 rounds per minute (rpm) on a shaker for approximately 8 h. Different dilutions 
of the pre-culture were prepared in 250 ml LB ranging from 1:25 to 1:1,000 for an 
optical density measured at a wavelength of 600 nm (OD600) < 1. Bacteria were 
cultured at RT and 230 rpm over night and during the next day until reaching an 
OD600 = 0.55 – 0.6. The suspension was chilled on ice for 10 min, followed by 
centrifugation at 2,500 g and 4 °C for 10 min. The remaining pellet was resuspended 
in 80 ml ice-cold ITB, chilled on ice for another 10 min and again centrifuged at 
2,500 g and 4 °C for 10 min. Once more the pellet was resuspended in 20 ml ice-cold 
ITB and incubated on ice for 10 min. 1.5 ml DMSO were added to achieve a final 
concentration of 7 %, mixed gently and the suspension aliquoted on ice. The 
competent cells were flash frozen in liquid nitrogen and stored at -80 °C.  
 
4.8.2 Heat shock transformation of E. coli 
Heat shock transformation is a frequently used method for enhancing the 
introduction of exogenous plasmid DNA into competent bacterial cells. For this 
purpose, 0.5 µl DNA were mixed with 19 µl of chemically competent E. coli and 
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incubated on ice for 10 min. The heat shock was performed in a pre-heated thermal 
mixer at 42 °C for 1 min, followed by chilling the bacteria on ice for another 2 min. 
E. coli were afterwards spread on LB plates and incubated at 37 °C over night. 
Depending on the introduced plasmid LB plates typically contained either 100 µg/ml 
ampicillin or 30 µg/ml kanamycin for selection purposes. Bacteria being selected for 
ampicillin could be immediately spread on the respective LB plates. On the contrary, 
bacteria that were expected to be resistant to kanamycin were incubated in 1 ml LB 
medium without antibiotics at 37 °C and 500 rpm on a shaker for 40 min. 
Afterwards, E. coli were pelleted by centrifugation at 3,350 g for 2 min, resuspended 
in 100 µl LB medium and finally spread on LB plates. The day after transformation, 
results were evaluated by counting the newly formed bacterial colonies.    
  
4.8.3 Electroporation of E. coli  
An alternative tool utilized for the transformation of bacterial cells is the short 
application of an external electric field. Thus, holes are created within the cell 
membrane thereby facilitating the uptake of plasmid DNA for a transient period of 
time. In this study, the electroporation of E. coli was exclusively conducted when 
performing homologous recombination events as part of the cloning procedure of 
adenoviral plasmids. For this purpose, electrocompetent E. coli BJ5183-AD-1 were 
used.    
Hence, 5 µg of adenoviral vector DNA were mixed with 20 µl of electrocompetent 
E. coli, transferred into an electroporation cuvette and chilled on ice. The electric 
shock was performed in an electroporator by applying 2,500 V, 200 Ω and 250 µF. 
Afterwards, bacteria were resuspended in 500 µl LB medium without antibiotics and, 
in the case of adenoviral recombinants, immediately spread on LB plates containing 
30 µg/ml kanamycin for selection.  
 
4.8.4 Small and large scale preparation of plasmid DNA 
Plasmid DNA was extracted and purified from E. coli by using commercially 
available systems.  
The function of the Nucleo Spin Plasmid Kit, which is suitable for small scale 
plasmid preparation, is based on the principle of plasmid DNA liberation from 
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bacteria by alkaline lysis. The DNA is subsequently bound to a silica membrane, 
purified by washing and finally eluted in low salt buffer. Briefly, bacterial cells from 
1 - 5 ml over night culture were harvested by centrifugation at 11,000 g for 30 s. The 
pellet was resuspended in 250 µl Buffer A1 by vortexing followed by addition of 
250 µl Buffer A2 for cell lysis. After incubation at RT for 5 min genomic DNA and 
proteins were precipitated by using 300 µl Buffer A3. Samples were centrifuged at 
11,000 g for 5 min and the supernatant transferred to a plasmid column to which 
DNA was bound during a centrifugation step at 11,000 g for 1 min. The DNA was 
afterwards purified by washing with 600 µl ethanolic Buffer A4 and centrifugation at 
11,000 g for 1 min, followed by a second round of centrifugation at 11,000 g for 
2 min in order to dry the silica membrane. Finally, the purified plasmid DNA was 
eluted in 50 µl of AE buffer by incubation at RT for 1 min followed by 
centrifugation at 11,000 g for 1 min.  
For large scale plasmid preparation the Marligen PowerPrep HP Plasmid Purification 
System was used. Its working principle is equally based on alkaline lysis followed by 
a precipitation step. Purification of the released DNA is performed with help of an 
anion exchange resin with subsequent elution of the plasmid DNA under high salt 
conditions followed by isopropanol precipitation for desalting. In preparation, 
columns were equilibrated with 30 ml of equilibration buffer. Bacteria from 100 ml 
over night culture were harvested by centrifugation at 6,000 g for 10 min and 
resuspended in 10 ml Cell Suspension Buffer, followed by alkaline lysis in 10 ml 
Cell Lysis Solution at RT for 5 min. Proteins and genomic DNA were precipitated 
with 10 ml Neutralization Buffer and samples centrifuged at 15,000 g for 10 min. 
The supernatant was then transferred to an equilibrated column and the bound 
plasmid DNA subsequently washed with 60 ml Washing Buffer. In the following, the 
plasmid DNA was eluted with 15 ml Elution Buffer and precipitated by addition of 
10.5 ml isopropanol and centrifugation at 15,000 g and 4 °C for 30 min. After 
washing the pellet in 5 ml 70 % ethanol and one final round of centrifugation at 
15,000 g and 4 °C for 5 min the air-dried pellet was dissolved in 500 µl TE Buffer. 
Obtained DNA yields ranged from 0.4 – 2.8 µg/µl.  
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4.8.5 Measurement of nucleic acid concentrations 
Optical density (OD) measurement was performed in order to assess the 
concentration and purity of nucleic acids in solution. Hence, the respective samples 
were diluted in sterile H2O at a final volume of 100 µl and measured in an ultraviolet 
(UV) cuvette at a wavelength of 260 nm. Multiplication of the obtained extinction 
value (E260) with 50 (DNA samples) or 40 (RNA samples) under consideration of the 
dilution factor gave the overall nucleic acid concentration in ng/µl. By additional OD 
measurement at a wavelength of 280 nm, respectively 230 nm, information could be 
obtained concerning the purity of the analyzed samples. Accordingly, contamination 
with proteins gave an E260/280 < 1.8 for DNA and E260/280 < 2 for RNA. Impurity due 
to salt or solvents showed as E260/230 < 2 for DNA and RNA samples. Typically, 
DNA samples used in cloning procedures displayed an E260/280 ≥ 1.8 and  E260/230 ≥ 2. 
 
4.8.6 Agarose gel electrophoresis 
During cloning procedures DNA fragments were analyzed according to their 
molecular size by agarose gel electrophoresis. Therefore, 0.4 % or 1 % agarose was 
dissolved in 1 x TAE buffer by microwave heating. For later visualization of the 
DNA samples under UV light 3.5 µl 10 mg/ml ethidiumbromide were added before 
pouring the mixture into a sealed gel casting tray. Samples were mixed with 6 x 
DNA loading dye and filled into the gel pockets. 5 µl of a 1 kb molecular weight 
standard were loaded on each gel, thus allowing the identification of DNA samples 
in a range of 250 – 10,000 bp by comparison with the utilized standard marker. 
Agarose gels were run at 100 – 120 V for 30 – 60 min and results documented by 
photography.  
 
4.8.7 Polymerase chain reaction (PCR) 
The method of PCR was first described by Mullis et al. (Mullis et al., 1986) and 
within this work used in order to generate DNA fragments to which restriction sites 
for later cloning steps were added. Thus, preparative PCR was performed as 
indicated below. Results were analyzed by agarose gel electrophoresis.  
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Table 23: Standard conditions for performing a preparative PCR. 
1 x PCR reaction mix program 
  1 µl DNA (1 µg/µl) 5 min 94 °C 
33 µl H2O   
  5 µl 10 x reaction buffer 30 s 94 °C 
  6 µl MgCl2 (25 mM) 30 s 59 °C 
  2 µl dNTP mix (10 mM each) 30 s 72 °C 
 
       
     20 cycles 
 
  1 µl forward primer (100 pmol)   
  1 µl reverse primer (100 pmol) 7 min 72 °C 
  1 µl Taq DNA Polymerase hold 4 °C 
 
4.8.8 Restriction digest 
The preparative specific cleavage of DNA fragments by restriction enzymes was 
used during cloning procedures in order to generate fragments needed for ligation or 
to linearize adenoviral plasmids for homologous recombination events. In addition, 
analytical restriction digests were performed to control the outcome of cloning 
procedures.  
A typical reaction mix was composed of 1 – 5 µg DNA, the appropriate restriction 
enzyme in 2 – 10 x excess as well as 3 - 5 µl 10 x reaction buffer and was adjusted to 
a final volume of    30 – 50 µl for preparative digests or 10 µl for analytical purposes 
with H2O. If required, 100 ng/µl BSA were included in the mixture. The amount of 
utilized enzyme was calculated in reference to the specific enzyme activity, 
considering that 1 unit of enzyme would digest 1 µg of DNA within 1 h. Reactions 
were carried out at 37 °C for 1.5 – 3.5 h, followed by heat inactivation of the enzyme 
at 80 °C for 20 min if necessary.  
 
4.8.9 Purification of DNA 
The purification of DNA samples was performed by using the Nucleo Spin Extract 
Kit II, a system which is based on the binding of DNA to a silica membrane followed 
by washing with ethanolic buffer. The pure DNA is subsequently eluted in low salt 
buffer.  
Typically, DNA purification was necessary during cloning procedures either in order 
to clean up samples after restriction digest or PCR or following agarose gel 
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electrophoresis so as to extract DNA samples from the respective agarose gel. In the 
latter case, fragments were excised from the agarose gel and the weight was 
determined. 200 µl of Binding Buffer NT were added per each 100 mg agarose and 
samples incubated at 50 °C for 5 – 10 min to completely dissolve the agarose. 
Alternatively, one volume of sample obtained from PCR or restriction digest was 
mixed with two volumes of Binding Buffer NT. Subsequently, the individual 
samples were loaded onto columns and the contained DNA bound to the silica 
membrane by centrifugation at 11,000 g for 1 min. Samples were washed with 700 µl 
Washing Buffer NT3 and again centrifuged at 11,000 g for 1 min, followed by a 
second centrifugation step at 11,000 g for 2 min in order to dry the silica membrane. 
Purified DNA was afterwards eluted in 15 – 50 µl Elution Buffer NE by incubation 
at RT for 1 min and subsequent centrifugation at 11,000 g for 1 min.  
 
4.8.10 Ligation 
Ligation reactions were carried out in order to clone a gene of interest into an 
appropriate expression vector during the generation of adenoviral plasmids, typically 
using restriction digests and purified DNA fragments. Due to the use of a quick 
ligation systems reactions could be carried out in a minimum time and at RT. For 
every ligation approach two controls were prepared, containing either only vector or 
insert DNA whereas the specific ligation sample possessed both parts. Reaction 
mixtures were prepared as shown in Table 24 and incubated for 10 – 15 min at RT, 
followed by heat shock transformation in E. coli.  
 
Table 24: Reaction mixtures and conditions for standard ligation procedures. 
vector control insert control ligation sample chemical 
1.0 µl - 1.0 µl vector 
- 1.0 µl 1.0 µl insert 
2.5 µl 2.5 µl 2.5 µl 2 x Quick ligation buffer 
1.0 µl 1.0 µl - H2O 
0.5 µl 0.5 µl 0.5 µl Quick T4 DNA Ligase 
10 - 15 min, RT 
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The next day, the outcome of the ligation reaction was evaluated by counting the 
bacterial colonies. In case of a successful ligation no colonies were to be expected for 
the insert control, whereas colonies obtained from the vector control indicated self 
ligation of the vector and allowed for the estimation of the percentage of positive 
colonies for the ligation approach. 
 
4.8.11 Cloning of adenoviral plasmids 
Adenoviral plasmids were generated in order to produce adenoviruses for transient 
infection of target cell lines. Therefore, the AdEasy cloning system was used 
following the protocol described by He et al. (He et al., 1998) as well as Luo et al. 
(Luo et al., 2007). In general, the procedure is based on a two-vector-system 
consisting of shuttle plasmids as well as adenoviral backbone plasmids. The specific 
gene of interest is first cloned into a shuttle-vector by standard cloning procedures. 
There are different shuttle vectors available which usually harbour the 5’ end of the 
adenoviral genome with early gene E1 and other genes, such as E2, E3 or E4, being 
deleted in order to generate space for transgene incorporation and prevent adenoviral 
replication. Expression of the gene of interest is driven by a CMV promoter. As a 
special feature, pAdTrack shuttle vectors contain a transgene independent GFP 
cassette which can be used as a control for successful infection of the various target 
cells. Shuttle vectors expressing the respective gene of interest are subsequently 
linearized and recombined into adenoviral backbone vectors by homologous 
recombination in E. coli. The resulting vector contains all genes required for virus 
production in a specialized packaging cell line but lacks genes essential for 
adenovirus production in naturally occurring cells.  
In this work two different adenoviral expression plasmids were cloned, CD36.pAdv 
and GFP-CD36.pAdv, aiming to achieve an overexpression of FLAG tagged human 
CD36 in the respective target MDCK cell lines.  
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CD36.pAdv 
Human CD36FLAG was amplified by PCR from template CD36-FLAG.pcDNA3, 
thereby adding restriction sites for later cloning steps to the CD36FLAG sequence. For 
PCR,  s_CD36.FLAG(adeno) was used as sense primer and a_CD36.FLAG(adeno) 
as antisense primer. The resulting PCR product was run on an agarose gel, purified 
and subsequently cut using the restriction enzymes BglII and XhoI. Vector 
pAda/pshuttle-CMV was equally digested with BglII and XhoI, followed by agarose 
gel electrophoresis. The DNA band of the appropriate size was extracted from the gel 
and purified. A standard ligation procedure was performed in order to generate 
adenoviral shuttle plasmid CD36.pAda and resulting clones screened by restriction 
digest with NdeI. Successful cloning of CD36.pAda was confirmed by sequencing. 
Shuttle plasmid CD36.pAda was subsequently linearized by digestion with PmeI, 
purified and introduced into BJ5183-AD-1 electroporation competent E. coli. 
Thereby, homologous recombination events were triggered aiming at the 
incorporation of CD36.pAda into the adenoviral backbone vector pAdEasy-1, thus 
generating CD36.pAdv. Resulting clones were analyzed by restriction digest with 
PacI and positive clones identified due to their characteristic appearance on an 
agarose gel with DNA bands being evident at 30 kb and 3 kb, alternatively 30 kb and 
4.5 kb.  
 
GFP-CD36.pAdv 
During the cloning of GFP-CD36.pAdv XbaI was used. Depending on the flanking 
sequences of the restriction site the enzyme may be sensitive to methylation by Dam 
methylases. This required part of the cloning process to take part in Dam negative 
bacterial cells. Hence, the appropriate plasmids primarily had to be transformed into 
Dam negative E. coli and the respective plasmid DNA prepared in order to enable 
successful cloning.  
Vector plasmid pEGFP-N1 and insert plasmid GFP-CD36-FLAG were initially 
digested with AgeI and XbaI, run on an agarose gel and the specific products 
purified. A standard ligation reaction was performed to create subcloning plasmid 
GFP-CD36.pNice. Resulting bacterial colonies were screened for positive clones by 
restriction digest with KpnI and XbaI. The newly created plasmid GFP-CD36.pNice 
as well as the adenoviral vector pAda/pshuttle-CMV were subsequently cut with 
KpnI and XbaI, ran on an agarose gel and the specific DNA bands purified. After 
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performing a standard ligation procedure clones were analyzed by restriction digest 
with BglII and results verified by sequencing. The newly cloned adenoviral shuttle 
plasmid GFP-CD36.pAda was afterwards linearized with PmeI, purified and 
transformed into BJ5183-AD-1 E. coli by electroporation. By homologous 
recombination of GFP-CD36.pAda and the adenoviral backbone vector pAdEasy-1 
the adenoviral expression plasmid GFP-CD36.pAdv was created. Again, successful 
cloning was verified by digestion with PacI.  
 
4.9 Biochemistry techniques 
4.9.1 Bradford protein assay 
The total protein concentration in a solution was determined by a colorimetric assay 
based on the protocol of Bradford (Bradford, 1976). The Bradford protein assay dye 
contains Coomassie brilliant blue R-250 which can display either red or blue 
coloring. Protein binding stabilizes the blue form of the dye with an absorption 
maximum of 595 nm. Thus, the increase in absorption is directly proportional to the 
amount of blue dye in the solution and therefore can be used as a measure for protein 
content.  
Cells were lysed in 1 N NaOH, therefore BSA was dissolved at 1 mg/ml in 1 N 
NaOH in order to establish a calibration curve samples could be compared to. A BSA 
dilution series from 2 – 12 ng in 1 N NaOH was prepared and adjusted to a final 
volume of 25 µl. For protein measurement, cells were harvested by incubation in 1 N 
NaOH for 60 min. 25 µl of each BSA dilution as well as different amounts of the 
respective sample were loaded in triplicates on a 96-well cell culture plate. The 
Bradford protein assay dye stock solution was diluted 1:5 in H2O and 200 µl thereof 
added to each well. Absorption was measured in a microplate reader at 595 nm and 
sample values analyzed by reference to values obtained from the BSA standard 
curve.    
 
4.9.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
The method of SDS-PAGE allows the separation of proteins depending on their 
specific chain length. SDS, an anionic detergent, linearizes proteins and charges 
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them negatively thus allowing a separation by size depending on the electrophoretic 
mobility of the respective proteins in a polyacrylamide gel.  
Gels were cast in two steps, starting with the preparation of the 8 % resolving gel. 
Components were used in amounts as indicated below (Table 25) and mixed by 
vortexing before and after addition of TEMED which initiated the polymerization of 
the gel. The mixture was applied to a gel caster system and isopropanol added on top 
of the gel in order to smoothen the surface and prevent formation of bubbles. In a 
second step, the 5 % stacking gel was prepared under the same conditions and poured 
on top of the resolving gel after the isopropanol had been discarded. For better 
visualization of the gel pockets a small amount of bromphenolblue was added. Gel 
pockets for sample application were formed by insertion of a comb in the gel caster 
system. Hardened gels were either stored in moist paper at 4 °C or immediately used 
for gel electrophoresis.  
 
Table 25: Composition of stacking and resolving gels as used in SDS-PAGE. 
Stacking gel (5 %) resolving gel (8 %) 
      1.7 ml H2O     2.55 ml H2O 
   312.5 µl 0.5 M Tris/HCl pH 6.8     1.00 ml 2 M Tris/HCl pH 8.8 
   425.0 µl 30 % acrylamide/bis solution     1.35 ml 30 % acrylamide/bis solution 
     25.0 µl 10 % APS         50 µl 10 % APS 
     25.0 µl 10 % SDS         50 µl 10 % SDS 
                         vortex                            vortex 
       2.5 µl TEMED           4 µl TEMED 
 
For sample preparation, cell pellets were dissolved in 2 x Laemmli buffer and heated 
at 95 °C and 1,400 rpm on a shaker for 5 min thus leading to the denaturation of 
proteins. When loading the gel, 5 µl of a protein molecular weight marker were 
applied to one of the gel pockets in order to later serve as size standard to which 
sample signals could be compared to. 15 – 30 µl of the respective samples were 
applied to the remaining gel pockets and the gel was run at 120 V, 200 mA and 50 W 
for 70 min in running buffer. The progress of the gel electrophoresis could be 
monitored by observation of the tracking dye bromphenolblue which was included in 
the Laemmli buffer and due to its low molecular weight moved ahead of most of the 
negatively charged proteins towards the positively charged anode.  
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4.9.3 Western blotting 
By using the Western blotting technique proteins that have been separated by gel 
electrophoresis are transferred to a nitrocellulose membrane and afterwards detected 
by incubation with specific antibodies. Consequently, this process makes proteins 
available for subsequent densitometric quantification.   
Proteins were transferred from the respective SDS gel to nitrocellulose membranes 
by the semi-dry blotting procedure. Therefore, for every gel to be blotted two stacks 
of three blotting papers cut to approximate gel size were soaked in blotting buffer. A 
nitrocellulose membrane was cut to gel size and shortly soaked in blotting buffer. 
The SDS gel was equally incubated in blotting buffer before being transferred onto 
one blotting paper stack sitting in a semi-dry blotting chamber. The equilibrated 
nitrocellulose membrane and the second blotting paper stack were piled on top and 
potential air bubbles removed by gently applying pressure onto the stack from the 
middle towards the border. Electroblotting was performed by administering 
100 mA/blotted gel at 120 V and 50 W for 1 h, thus pulling the negatively charged 
proteins from the SDS gel onto the nitrocellulose membrane towards the positively 
charged electrode of the blotting chamber.   
The efficiency of the protein transfer was controlled by subsequent staining of the 
nitrocellulose membrane in Ponceau Red, a dye with a detection limit of protein 
amounts around 0.5 – 1 µg. Its water solubility enables an intense, non-permanent 
and unspecific protein staining with low background signal. Results were 
documented by scanning of the stained membranes.  
In order to prevent unspecific antibody binding during following incubation steps 
membranes were first of all blocked in 2 % nonfat dry milk dissolved in TBS-Tween. 
Incubation was carried out under gentle agitation for 30 min at RT. For specific 
labeling of a given protein the respective primary antibody was diluted in 2 % nonfat 
dry milk dissolved in TBS-Tween and applied to the blocked membrane. Samples 
were then incubated at RT for 1 h or at 4 °C over night on a rocker. Thereafter, 
membranes were washed several times in TBS-Tween to eliminate unbound antibody 
residues and subsequently incubated with the respective species-specific secondary 
antibody equally diluted in 2 % nonfat dry milk dissolved in TBS-Tween. After 
incubation at RT for 1 h blots were again rinsed several times in TBS-Tween for 
residual antibody removal.  
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All utilized secondary antibodies are linked to the reporter enzyme horseradish 
peroxidase which under cleavage of a chemiluminescent agent produces a 
luminescent signal that can be detected by exposure to a photographic film. The 
obtained signal is proportional to the amount of bound protein and can thus be used 
as a measure for protein quantity. Hence, the readily probed and washed membranes 
were air-dried, covered with ECL solution and incubated at RT for 1 min. 
Membranes were then exposed to photographic Amersham Hyperfilm ECL films in a 
darkroom. Films were afterwards developed by using a commercial developer 
machine and signals quantified with ImageJ.  
 
4.9.4 SDS-PAGE analysis with ImageJ 
ImageJ is an open source program for image processing that has been developed at 
the National Institute of Health with one of its potential applications including the 
densitometric quantification of western blot signals.  
Results obtained by western blotting were digitalized by scanning the developed 
photographic films and saving them as jpg.files at 300 dots per inch (dpi). The single 
protein bands were measured using ImageJ, resulting in one profile blot for each 
captured signal. Profile blots showed the relative density of the respective lanes, with 
darker signals giving higher peaks and broader signals resulting in wider peaks. 
Background signals were substracted from the final quantification value by drawing 
a baseline on the bottom of each peak, thereby excluding the underlying area from 
the measurement. The obtained numbers for the measured areas under the peaks 
showed arbitrary units and could thus only be compared within the context of one 
single blot. In order to calculate absolute amounts of specific proteins the dilution 
series of an appropriate purified protein was loaded on each gel together with the 
respective samples. During the quantification process a standard curve was 
established using the arbitrary units obtained from the signals of the dilution series. 
Afterwards, the absolute amount of a specific protein on a western blot was 
calculated by referring its arbitrary units to the appropriate standard curve. Hence it 
was possible to quantify ng protein of any given protein signal.   
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Figure 5: Quantification of western blot signals by using ImageJ.  
Western blot lanes were quantified using ImageJ with obtaining a profile blot for each measured lane. 
Darker signals resulted in higher peaks, thus indicating a higher amount of detected protein on the 
blot.  
 
4.9.5 Coomassie blue protein staining 
Coomassie brilliant blue, an anionic dye, is commonly used for the unspecific 
staining of proteins and allows the visualization of protein bands in a SDS gel. 
After finishing the SDS-PAGE process gels were incubated in 0.1 % comassie blue 
staining solution under gentle agitation for at least 2 h on a rocker. Due to the 
contained acetic acid proteins were simultaneously fixed. In order to reduce the 
background signal, gels were subsequently washed for several hours in destain 
solution which was identical to the staining mixture but lacking the dye. If the 
destaining process was not completely finished after several hours a final destain step 
was performed at 4 °C over night. The following day, stained gels were digitalized 
by scanning and signals quantified using ImageJ.  
 
4.9.6 Protein purification 
In order to generate protein standards for western blot analysis the ANTI-FLAG M2 
affinity gel system from Sigma-Aldrich was used. Its functional principle is based on 
mouse IgG monoclonal antibodies that are covalently bound to agarose beads which 
allow for the purification of FLAG fusion proteins.  
Thus, MDCK cells stably overexpressing FLAG-tagged FATP4 protein were seeded 
on 145 cm2 cell culture dishes and grown to confluence. Cells were harvested with a 
rubber scraper and pelleted by centrifugation at 100 g and 4 °C for 5 min, followed 
by washing in 1 x PBS and repetition of the centrifugation step. The resulting pellet 
was either stored at –80 °C or immediately used for protein purification.  
In preparation, the agarose beads were washed in order to eliminate the glycerol 
contained in the storage solution and to resuspend the beads in the respective 
working buffer. For each three 145 cm2 cell culture dishes 25 µl agarose gel beads 
were taken up in 500 µl TNEX buffer, mixed by vortexing and centrifuged at 1,000 g 
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and 4 °C for 5 min. This step was repeated twice, finally discarding all but 50 µl of 
residual buffer volume containing the washed agarose beads.  
A cell pellet harvested from three 145 cm2 cell culture dishes was resuspended in 
1.5 ml TNEX buffer and incubated on ice for 30 min with pipetting the mixture up 
and down after 10 min and 20 min. The Triton X-100 contained in the TNEX buffer 
was used to disrupt cell membranes and solubilize proteins for further purification 
steps. The sample was then centrifuged at 1,000 g and 4 °C for 5 min in order to 
separate cell debris and solubilized components. The supernatant was transferred into 
a new reaction tube and again centrifuged, this time at a higher speed of 13,000 g at 
4 °C and for a prolonged time of 15 min to eliminate remaining debris. The resulting 
supernatant was carried over into the reaction tube containing the washed agarose 
beads. FLAG fusion proteins were bound to the IgG covered beads over night at 4 °C 
while rotating at slow speed. The following day, beads were sedimented by 
centrifugation at 1,000 g and 4 °C for 5 min. The bead-bound proteins were washed 
twice in 1 ml TNEX buffer and twice in 1 ml TNE buffer in order to eliminate the 
Triton X-100, always followed by centrifugation under the above conditions. After 
the final round of centrifugation all supernatant was carefully discarded, the 
remaining sample resuspended in 60 µl SDS-PAGE special sample buffer and 
incubated at 95 °C for 5 min at 1,400 rpm on a shaker. For later western blot analysis 
0.6 µl ß-mercaptoethanol were added for protein denaturation and samples again 
incubated at 95 °C for 5 min at 1,400 rpm on a shaker. The purified proteins were 
subsequently stored at -20 °C until further use. Purification of FLAG-tagged FATP4 
protein was performed at two different time points, yielding samples with 18,7 ng/µl 
and 47,5 ng/µl, respectively.  
 
4.9.7 Establishment of a FATP4FLAG protein standard 
For quantification of the specific amount of overexpressed CD36FLAG, FATP4 or 
ACSL1FLAG protein within a given cell pellet the purified protein standard 
FATP4FLAG was used. Briefly, results were obtained by comparing different amounts 
of the specific sample to a FATP4FLAG standard curve via western blotting.  
First of all, purified FATP4FLAG protein was quantified. Therefore, 1/4 - 1/3 of the 
total protein amount was loaded on a SDS gel together with a dilution series of BSA 
in 1 x PBS, ranging from 0.25 – 10 µg. Western blotting was performed and the 
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obtained protein bands analyzed by using ImageJ, thereby assessing the specific 
amount of FATP4FLAG protein in ng/µl. For subsequent analysis, two different 
amounts of the respective protein sample were applied to a SDS gel together with 
defined amounts of FATP4FLAG protein, thus yielding a standard curve to which 
sample signals could be compared to. Quantification of CD36FLAG and ACSL1FLAG 
protein was performed by using the rb-α-FLAG antibody whereas for analysis of 
FATP4 protein the rb-α-FATP4 (C3/5) antibody was applied.  
During the course of this work three different FATP4FLAG protein standards were 
prepared which differed in their specific concentration. In order to obtain reliable 
results, one of the three standards was chosen as reference to which the remaining 
two standards could be referred to. Accordingly, the same protein samples were 
quantified once by using the reference standard and once by using one of the 
remaining standards. Results were analyzed by ImageJ and if necessary a correction 
factor calculated for the analyzed standard.  
For production and purification of protein standards two different versions of the 
FLAG-tagged FATP4 protein were used, including full length FATP4 (FATP4FLAG) 
as well as a shortened version of FATP4 (FLAG FATP4), running at 72 kDa and 
33 kDa respectively. The latter protein was lacking its membrane anchor for 
facilitation of the purification process und had a FLAG-tag attached to the                
N-terminus (as opposed to the C-terminal FLAG-tag of the full length protein). 
Western blot analysis revealed that the localization of the FLAG-tag had an influence 
on the signal strength obtained by application of the rb-α-FLAG antibody. 
Accordingly, the C-terminal FLAG accounted for a stronger signal than the N-
terminally located FLAG-tag. Thus, when comparing the shortened FLAGFATP4 
standard protein to the reference standard two independent correction factors had to 
be calculated: one for the rb-α-FLAG antibody and a second one for the rb-α-FATP4 
(C3/5) antibody. 
 
4.9.8 Protein quantification by western blotting 
To quantify protein expression levels, 22 h after seeding MDCK cells were harvested 
by trypsinization from 12-well cell culture plates (1 well/sample). Cell pellets were 
taken up in 100 µl 2 x Laemmli buffer and further diluted up to 1:100 in 2 x Laemmli 
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buffer for FATP4 and ACSL1 samples if the specific protein amounts were very 
high.  
Two different quantities of each sample were loaded on a SDS gel together with a 
dilution series of FATP4FLAG protein standard to establish a standard curve. The 
range of the dilution series was adapted depending on the amount of loaded protein 
samples, reaching from 0.125 – 15 ng. After western blotting, protein bands were 
quantified by densitometric analysis. Absolute quantities of CD36FLAG, FATP4 and 
ACSL1FLAG protein were calculated by reference to the FATP4FLAG standard curve. 
For each sample, the respective mean was assessed. An exemplary quantification is 
shown in Figure 6. 
 
Figure 6: Quantification of FATP4 protein amounts by western blotting. 
Wildtype MDCK cells infected with FATP4 adenovirus were harvested from 12-well cell culture 
plates by trypsinization. Two different protein amounts of the same sample were loaded on a SDS gel, 
with the higher amount loaded in duplicates. A FATP4FLAG protein standard dilution series was 
applied to the same gel. Protein bands obtained from western blotting were analyzed densitometrically 
with ImageJ and sample values related to the FATP4FLAG standard curve. 
 
4.9.9 Radioactive oleate uptake assays 
In order to determine the capacity of different kinds of cells to take up fatty acids 
under various conditions radioactive oleate uptake assays were performed. Cells 
were incubated with ³H-oleic acid mixed with non-radioactive oleate. With reference 
to the incorporated amount of radioactivity the overall oleate uptake was calculated.  
In preparation of performing the assay MDCK cells were seeded the previous day at 
a density of 400,000 cells/well on 12-well cell culture plates. For all experiments 
cells were cultured in triplicates. Whenever necessary MDCK cells were infected 
with the appropriate adenovirus 6 h after seeding and incubated over night. The 
following day, a radioactive labeling mix was prepared immediately before starting 
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the assay. A typical labeling mix was composed of 200 µM oleate and 100 µM BSA 
with 0.5 Ci/mol. The appropriate amounts of non-radioactive oleic acid stock and  
3H-oleic acid were mixed and the respective solvents evaporated under a weak 
nitrogen flow. In the following, the remaining fatty acids were taken up in 25 mM 
NaOH and subsequently bound to 800 µM fatty acid free BSA by vortexing. Culture 
medium without FBS was added up to the final volume, again mixed by vortexing 
and until further use stored at 37 °C.  
 
Table 26: Composition of a labeling mix as used in radioactive uptake assays.  
labeling mix 
amount concentration chemical 
    45.2 µl  20 µg/µl oleic acid stock 
      1.6 µl  1 µCi/µl ³H-oleic acid (50 µM) 
evaporation of solvent under nitrogen flow 
  153.6 µl    25 mM NaOH 
  2,000 µl   800 µM BSA without fatty acids 
13,846 µl      - culture medium without FBS 
 
Approximately 22 h after seeding 800 µl of prewarmed labeling mix were applied to 
each well and incubated for either 5 min or 3 hours, the latter taking place at 37 °C 
and 5 % CO2. To stop the reaction and prevent further fatty acid uptake, cells were 
washed twice with ice-cold STOP-mix after the indicated time followed by two 
washing steps with ice-cold PBS. Remaining fatty acids were thus bound by the BSA 
contained in the STOP-mix, whereas the PBS removed residual BSA in order to 
prevent falsification of the results later obtained in the Bradford protein assay. Cells 
were subsequently lysed by incubation in 500 µl 1 N NaOH per well for 1 h at RT. 
Lysates were afterwards transferred to Safe-Lock tubes and vortexed vigorously. 
250 µl of lysate were used for the quantification of the contained radioactivity in a 
liquid scintillation counter while part of the remaining sample served for 
determination of the total protein amount by using the Bradford protein assay.  
For final analysis, the overall amount of incorporated fatty acids was calculated by 
referring to the respective radioactive proportion of utilized oleic acid. This value 
was subsequently related to the measured protein amount of the given samples, 
stating the quantity of oleate taken up in reference to the amount of protein        
[pmol oleate/µg protein]. 
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4.10 Cell culture techniques 
4.10.1 Culture of immortalized cell lines 
All cell culture experiments were carried out by using immortalized, adherently 
growing cell lines. According to their specific properties, cells were utilized for 
radioactive uptake assays, sample collection for western blots, immunofluorescence 
or virus production.  
 
MDCK cells 
MDCK cells are epithelial, immortalized cells that were derived from the kidney of a 
female adult cocker spaniel in 1958. This cell line is frequently used in order to study 
transport processes as the cells show a clear apico-basolateral polarity and can be 
easily polarized in cell culture. In this study, all analytical experiments were carried 
out by utilizing MDCK cells.  
 
Hek293 cells 
Hek293 cells originate from human embryonic kidney cells which have been 
transformed with adenovirus 5 DNA. When growing in cell culture the cells show 
rather weak adherence which allows easy harvesting. This cell line provides proteins 
that are lacking in commonly used adenoviral vectors, thus enabling the replication 
of adenoviruses in a cell culture system.  
 
Phoenix gp cells 
Phoenix gp cells are a packaging cell line suitable for the production of retroviruses. 
They originate from a human embryonic kidney cell line and are highly transfectable 
with calcium phosphate. In comparison to other packaging cell lines, Phoenix gp 
cells exclusively express the retroviral proteins gag and pol and therefore allow for 
virion pseudotyping.  
 
All cells were kept in an incubator at 37 °C and 5 % CO2 and during propagation 
procedures exclusively handled under sterile conditions. For passaging, the 
respective culture medium was discarded and cells were washed once with 1 x PBS 
in order to remove medium residues. For resuspension of cells, 2 ml trypsin/T75 
flask were applied and incubated at 37 °C and 5 % CO2 for 5 min (Phoenix gp, 
Hek293) to 30 min (MDCK). Trypsin, a serine protease, cleaves protein bounds 
between adherent cells and the surface of cell culture dishes thus allowing the gentle 
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removal of adherent cells. Subsequently, cells were resuspended in fresh culture 
medium and transferred to new flasks in proportions of 1/2 to 1/8 as indicated below.  
 
 
Table 27: Culture conditions for immortalized, adherently growing cell lines.  
cell line characteristics medium passaging 
MDCK canine kidney cells  MEM  
at post-confluency, 
1/2 for assays,  
1/8 for propagation 
Hek293 human embryonic kidney cells containing 
adenovirus 5 DNA DMEM 
at sub-confluency,  
1/6 for propagation 
Phoenix gp gag pol expressing human embryonic kidney cells DMEM at sub-confluency,  1/6 for propagation 
 
4.10.2 Freezing and thawing of cells  
For long-time storage cells were kept frozen in sterile cryotubes and stocked in liquid 
nitrogen. Typically, cells were grown to subconfluency in a T175 cell culture flask 
and harvested by trypsinization. 20 ml ice-cold standard culture medium were used 
for resuspension and cells were sedimented by centrifugation at 4 °C and 100 g for 
5 min. The supernatant was discarded and cells were taken up in 5 ml ice-cold 
culture medium containing 10 % DMSO. 1 ml cell stock aliquots were initially 
cooled down at a rate of 1 °C/h by sitting in an isopropanol filled freezing device at -
80 °C. After several days, stocks were transferred to liquid nitrogen for extended 
storage periods.  
To start a new cell culture batch stocks were thawed rapidly either at RT or in a 
37 °C preheated water bath. In order to dispose of the DMSO cells were taken up in 
20 ml ice-cold fresh culture medium and sedimented by centrifugation at 100 g for 
5 min. The supernatant was discarded, cells were resuspended in 15 ml prewarmed 
medium and cultured under standard conditions. 
 
4.10.3 Counting cells 
In order to maintain comparable conditions between different experiments cells were 
counted before seeding. Hence, trypsinized cells were resuspended in fresh culture 
medium and an aliquot of several µl was counted by using a Neubauer improved 
counting chamber. Four independent quadrants covered by the cell suspension were 
counted and the mean value was calculated. Finally, the number of cells per ml was 
determined by multiplication of the obtained value with 10,000.  
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4.10.4 Production of cell pellets  
For western blot analysis cells were grown in 12-well cell culture plates and at the 
appropriate time point harvested by trypsinization as usual. Cells were resuspended 
in culture medium, transferred to 1.5 ml Eppendorf Safe-Lock tubes and sedimented 
by centrifugation at RT and 200 g for 5 min. The supernatant was discarded and the 
remaining pellets were washed once in 1 x PBS, followed by centrifugation at RT 
and 200 g for 5 min. The PBS was again discarded and pellets were stored at -80 °C 
until further use.  
 
4.10.5 Transient transfection of cells by lipofection 
Lipofection is a method of introducing plasmid DNA into cells in order to obtain a 
transient overexpression of the inserted genetic material. Lipofection reagents form 
liposomes in an aqueous environment which contain the respective plasmid DNA. 
By fusion of the phospholipid liposome with the phospholipid cellular membrane an 
efficient introduction of the genetic material into the cell is enabled. In this study 
Lipofectamine 2000 was used as lipofection reagent.  
For standard procedures cells were seeded the previous day, preferably reaching a 
density of 60 - 80 % at the time point of transfection. 1 h prior to transfection the 
culture medium was replaced by medium without antibiotics and cells kept again at 
37 °C and 5 % CO2. Two different master mixes were prepared, incubated at RT for 
5 min, mixed and incubated for another 20 min at RT. 200 µl lipofection mix/12-well 
were added dropwise to the medium and cells were cultured for at least 4 h under 
standard conditions. The transfection medium was then replaced by medium without 
antibiotics.     
 
Table 28: Master mix preparation for Lipofectamine transfection.  
1 x master mix for lipofection (12-well) 
master mix 1 master mix 2 
             2 µg DNA   
       add 4 µl H2O              4 µl Lipofectamine 2000 
          100 µl OptiMEM          100 µl OptiMEM 
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4.10.6 Generation of retroviruses 
The retroviral system is a powerful means for the delivery of genetic material into a 
variety of mammalian cell lines, resulting in an efficient and stable overexpression of 
a given gene. Although often utilized to achieve increased gene expression 
retroviruses can as well be used in order to obtain a gene knock down by RNA 
interference (RNAi), a mechanism that is based on the degradation of mRNA 
initiated by a corresponding doublestranded RNA (dsRNA).   
The amphotropic Phoenix system is based on the Moloney Murine Leukemia Virus 
(MMLV) and allows for the retroviral infection of most mammalian dividing cells. 
The Phoenix-gp producer cell line encodes the viral proteins gag (core proteins) and 
pol (reverse transcriptase). It can thus be pseudotyped with alternative viral envelope 
proteins by co-expression with a retroviral coding plasmid, thereby altering the host 
tropism of the respective virus. A commonly used variant for this purpose is the 
glycoprotein G of the Vesicular stomatitis virus (VSV-G) which promotes fusion of 
retroviral with cellular membranes and allows for the infection of a high variety of 
different mammalian cell types.  
For generation of retroviral particles the packaging cell line Phoenix-gp has to be co-
transfected with a plasmid encoding the gene of interest and the VSV-G plasmid, 
resulting in the production of infectious but replication deficient retroviral particles. 
The respective viral proteins gag, pol and env are therefore only expressed during 
culture of the packaging cell line. The produced retroviral particles can subsequently 
be used for the infection of various target cell lines, leading to the stable integration 
of the gene of interest into the cellular genome.    
The herein described protocol for the generation of retroviruses goes back to the 
publication by Schuck et al. (Schuck et al., 2004). In preparation, a 60 cm2 dish was 
covered with Collagen R solution and incubated at 37 °C for 1 h. Afterwards, 
remaining collagen was removed and collagen coated dishes stored at 4 °C. Two 
days before transfection 1.2 x 106 Phoenix-gp cells were seeded in a 60 cm2 dish. 
When reaching a confluency of 70 – 80 % 10 ml of fresh culture medium was 
applied and a master mix for CaPO4 transfection was prepared as indicated in    
Table 29 and incubated for 5 min at RT.      
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Table 29: Master mix preparation for CaPO4 transfection. 
1 x master mix for CaPO4 transfection (60 cm2) 
    add 540 µl H2O 
           4.5 µg pVSV-G 
         13.5 µg retroviral plasmid 
          132 µl 1 M CaCl2 
add 2 x HBS dropwise while vortexing 
          540 µl 2 x HBS pH 6.95 
 
The transfection mix was added dropwise to the cells and incubation was carried out 
at 37 °C and 5 % CO2 for 16 h. 10 ml of fresh culture medium were then applied and 
incubated for another 8 h under the same conditions. For harvesting of retroviral 
particles 24 h after transfection medium was changed to 5 ml of DMEM low glucose 
and cells subsequently incubated at 32 °C and 5 % CO2. Every 24 h the supernatant 
containing the freshly produced retroviral particles was collected and another 5 ml of 
DMEM low glucose were added to the Phoenix-gp packaging cells. Retroviral 
supernatants were passed through a sterile nitrocellulose free 0.45 µm syringe filter, 
shock frozen in liquid nitrogen and stored at –80 °C until further use. Collection of 
the retroviral particles was carried on for up to 8 days post transfection.   
 
4.10.7 Production of stable cell lines by retroviral infection 
For the generation of stable cell lines MDCK cells were seeded on 6-well cell culture 
plates aiming to reach subconfluency at the time point of infection. 24 h after seeding 
500 µl of sterile filtered retroviral supernatant together with 4 µg/ml Polybrene in 1 x 
PBS were added to each well and incubated for 24 h at 32 °C and 5 % CO2. 
Typically, approaches were performed in duplicates and cultured in parallel to 
uninfected control cells. In order to increase the efficiency of the retroviral infection 
process cells were cultured with retroviral supernatants on two consecutive days, 
followed by incubation in standard medium for another 24 h at 37 °C and 5 % CO2.  
Only cells with successful incorporation of the gene of interest had equally integrated 
a puromycin resistance gene which allowed for the antibiotic selection of stably 
expressing cells. Thus, samples were trypsinized, seeded again in new medium 
containing 8 µg/ml puromycin in 1 x PBS and cultured at 37 °C and 5 % CO2. 
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During the following days, each day medium was changed to fresh medium 
containing 4 µg/ml puromycin until all control cells had died. The remaining cells 
were cultured to confluence and stocks prepared for further experiments.  
 
4.10.8 Generation of adenoviruses 
Replication deficient adenoviruses are a powerful tool for obtaining high levels of 
transient transgene expression in a variety of different mammalian cell lines. Within 
the AdEasy system pAdEasy-1 is a commonly used adenoviral vector which has 
been deleted for the early genes E1 and E3, thus making the use of an E1-expressing 
packaging cell line such as Hek293 necessary for adenovirus production and 
propagation. The resulting recombinant adenovirus possesses the ability to infect 
dividing as well as non-dividing cells without being able to further replicate within 
the respective target cell line.      
Hek293 cells were seeded 24 h prior to transfection at a density of 1.5 x 106 cells per 
T25 cell culture flask. The following day, 10 µg of adenoviral recombinant DNA 
were digested with PacI in order to linearize the plasmid. Incubation was carried out 
at 37 °C for 4 h, followed by heat inactivation of the enzyme at 65 °C for 20 min.  
 
Table 30: Linearization of adenoviral plasmid DNA. 
restriction digest mix  
            10 µl DNA (10 µg) 
              3 µl PacI (10 U/µl) 
              5 µl NEB buffer 1 
              5 µl 10 x BSA
 
            27 µl H2O 
 
When reaching a confluency of 50 – 70 % Hek293 cells were washed once with 4 ml 
of OptiMEM and 2.5 ml of fresh OptiMEM were applied per T25 cell culture flask. 
The packaging cells were subsequently transfected with the linearized adenoviral 
plasmid DNA using Lipofectamine 2000 as the transfection reagent and incubated 
for 4 hours under standard cell culture conditions. The medium-transfection-mix was 
afterwards discarded and 6 ml of fresh medium added. Alternatively, if cells did not 
respond well to this protocol, DMEM without antibiotics was used instead of 
OptiMEM for incubation.   
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Table 31: Lipofection of Hek293 packaging cells using adenoviral plasmid DNA.  
1 x master mix for lipofection (T25) 
master mix 1 master mix 2 
            50 µl digest product             25 µl Lipofectamine 2000 
          625 µl OptiMEM          625 µl OptiMEM 
 
Adenoviral generation follows a cycle of virus attachment to the cell surface, uptake 
by receptor-mediated endocytosis and translocation into the nucleus where the viral 
replication takes place. Finally, viruses are released from the cell by inducing cell 
death. Lysis of the packaging cell line can therefore be used as a measure for 
proceeding adenoviral replication and is typically seen 7 – 10 days post transfection. 
At that time point the remaining cells were harvested by simply rinsing them off the 
flask wall as they detached very easily. Samples were pelleted by centrifugation at 
3,200 g and 4 °C for 5 min and resuspended in 1 ml ice-cold 1 x PBS. Viruses were 
subsequently released from the cellular nuclei by performing four freeze-thaw-cycles 
in order to disrupt the pelleted cells. Therefore, pellets were frozen in a dry ice-
MeOH-bath, thawed again in a 37 °C water bath and vortexed three times for 10 s 
with being chilled in between for 10 s on ice. Four rounds of freeze-thaw-cycles were 
performed, followed by centrifugation at 3,200 g and 4 °C for 1 min. The supernatant 
containing the recombinant adenovirus was stored at -20 °C until further use.  
As to increase the amount of produced adenovirus the harvested viral supernatants 
were subsequently used to infect increasing numbers of T75 and T175 cell culture 
flasks seeded with Hek293 cells. As soon as a third to half of the cells were detached 
adenoviruses were harvested as described above. For preparing a high titre stock 
packaging cells from 8 – 12 T175 cell culture flasks were infected with adenoviral 
supernatant and harvested when lysis became evident. After centrifugation at 1,000 g 
and 4 °C for 5 min the pellet was taken up in 8 ml ice-cold 1 x PBS and four rounds 
of freeze-thaw-cycles were performed. The sample was centrifuged at 3,200 g and 
4 °C for 1 min and the resulting supernatant mixed with 4.4 g CsCl by vortexing. The 
suspension was transferred to a polyclear ultracentrifugation tube, covered with 2 ml 
of mineral oil and centrifuged in an ultracentrifuge with SW 41-Ti rotor at 
32,000 rpm and 10 °C for 20 h over night. The following day the virus fraction was 
evident as a cloudy white band within the clear CsCl solution and could thus be 
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collected by using a syringe with an 18G needle attached. The high titre adenovirus 
stock was mixed to 50 % with 2 x storage buffer and stored at -20 °C.  
The adenoviral titre of the respective stock was assessed by infection of mammalian 
target cells with various dilutions of adenovirus and infection efficiency evaluated by 
immunofluorescent staining.  
 
4.10.9 Infection of cells with adenovirus 
Recombinant adenoviruses are capable of infecting dividing as well as non-dividing 
cells, therefore making the consideration of confluency much less important for 
infection rates as opposed to the methods of lipofection and retroviral infection.  
For adenoviral infection, cells were seeded at the desired density and incubated for 
6 h at 37 °C and 5 % CO2. The majority of experiments were performed using       
12-well cell culture plates with 400,000 MDCK cells being seeded in each well. 
Different conditions were tested for the process of adenoviral infection, including 
incubation in OptiMEM only as opposed to OptiMEM with additional standard 
medium as well as discarding the adenovirus after 1 h of infection or incubation of 
the cells with adenovirus over night. The respective infection efficiencies were 
evaluated by western blotting and radioactive oleate uptake assays and the most 
suitable protocol was used for all further experiments as described below.   
After 6 h of growth the culture medium was replaced by 200 µl OptiMEM containing 
the respective amount of adenovirus and incubated for 1 h at 37 °C and 5 % CO2. 
Adenovirus amounts were strongly dependent on the individual titre of each stock as 
well as on the particular protein expression rate and ranged from several nl to several 
µl per 12-well. Subsequently, 800 µl of standard cell culture medium were added to 
each well and incubation was carried out over night. Typically, cells were used for 
further analysis by radioactive oleate uptake assays or immunofluorescence 
approximately 16 h post infection.  
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4.10.10 Immunofluorescence 
Immunofluorescent staining allows the examination of the localization and 
expression of a particular protein within a cell by targeting it with a specific 
antibody. Subsequent binding of a species-specific secondary antibody which is 
coupled to a fluorophore enables the analysis of special distribution and intensity of 
expression by visualization under a fluorescence microscope.  
Cells were seeded the previous day at different densities on 10 mm cover slips, 
typically in a 12-well cell culture plate. If required, adenoviral infection was 
performed at the day of seeding and cells incubated over night. The following day, 
samples were washed twice in 1 x PBS followed by fixation in 4 % PFA for 20 min 
at RT. In order to remove the remaining PFA cells were again rinsed twice with 1 x 
PBS and either directly used for immunofluorescent staining or stored at 4 °C in 1 x 
PBS until further use.  
During the process of staining all incubation steps were performed by placing the cell 
covered side of the individual cover slips on a 30 µl droplet of SGB solution in a 
humidity chamber to prevent samples from running dry. In order to avoid unspecific 
binding of the utilized antibodies cells were initially blocked by incubation in SGB 
for 10 min at RT. The primary antibody was diluted in SGB, cover slips transferred 
to the appropriate antibody droplets and incubated at RT for 1 h. The appropriate 
species-specific secondary antibody was equally diluted in SGB. Cover slips were 
rinsed three times in SG solution to remove unbound antibody residues and 
transferred to the respective antibody droplets, followed by incubation in the dark at 
RT for 1h. If required, a co-staining of two antibodies diluted together in SGB could 
be performed under the same conditions.   
After finishing the second incubation step cover slips were washed twice in SG and 
1 x PBS each and embedded on a microscope slide using Mowiol as mounting 
medium. For unspecific staining of DNA the dye Hoechst 33342 was diluted 1:2,000 
in Mowiol, thus staining nuclear DNA during the mounting process. Samples were 
air-dried for several hours and afterwards stored at -20 °C. Analysis was performed 
by fluorescence microscopy. 
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4.11 Statistical analysis 
If not otherwise noted, radioactive oleate uptake assays were performed in triplicates 
and conducted three times under independent conditions. Each protein sample used 
for western blot analysis was quantified mostly in triplicates but at least in 
duplicates. Values are given as mean with standard deviation (SD). Statistical 
analysis was performed using the analysis function of Microsoft Office Excel by 
applying the two-sample t-test under the assumption of unequal variance.  
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5. Results 
Fatty acid uptake is facilitated by plasma membrane as well as intracellularly 
localized proteins like CD36, FATP4, ACSL1 and Cav-1 through different 
mechanisms. During this study, protein amounts of CD36, FATP4 and ACSL1 were 
quantified by comparison to a recombinant protein standard and related to respective 
alterations in oleate uptake. CD36, FATP4, ACSL1 and Cav-1 were tested for 
cooperative acting in mediating fatty acid uptake and their cellular localizations 
verified by immunofluorescence. 
 
5.1 Generation of stable MDCK cell lines  
Stable protein overexpressing and knock down MDCK cell lines were generated by 
retroviral infection of the respective wildtype strain. During this study, three different 
stable cell lines were used: 
 
- MDCK cells stably overexpressing ACSL1FLAG (ACSL1FLAG MDCK) 
- MDCK cells stably overexpressing FATP4 (FATP4 MDCK) 
- MDCK cells with stable knock down of Cav-1 (Cav-1 KD MDCK) 
 
ACSL1FLAG MDCK as well as Cav-1 KD MDCK cells were generated as part of this 
work whereas the FATP4 MDCK cell line was kindly provided by Margarete 
Poppelreuther (AG J. Füllekrug, University Hospital Heidelberg).  
 
5.1.1 ACSL1 overexpression in MDCK cells is achieved by retroviral infection 
Stable ACSL1FLAG protein overexpressing MDCK cells were generated by retroviral 
infection with subsequent puromycin selection. A second stable MDCK cell line was 
generated based on the retroviral expression vector pQCXIP-J and served as control. 
Puromycin selection of both cell lines was successfully performed as assessed by the 
killing of uninfected wildtype MDCK cells that were used for growth control. The 
effective overexpression of ACSL1FLAG protein was evidenced by protein 
quantification by western blotting and correlated with enhanced oleate uptake (see 
sections 5.3.7 and 5.3.8).  
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5.1.2 Cav-1 knock down diminishes protein expression levels by more than 80 % 
A Cav-1 KD MDCK cell line was generated by retroviral infection to determine the 
influence of Cav-1 on oleate uptake in wildtype and CD36 overexpressing cells. 
Knock down of Cav-1 expression was performed very efficiently as evidenced by 
western blotting (Figure 7 A).  
 
 
Figure 7: Quantification of Cav-
1 knock down in MDCK cells. 
 
A) Western blot showing protein 
expression levels of Cav-1 in 
knock down and wildtype MDCK 
cells. Equal amounts for Cav-1 
KD and 100 % wildtype MDCK 
cell lysates were loaded together 
with a dilution series of wildtype 
MDCK cell lysates. Cav-1 KD 
MDCK cells show  significantly 
diminished expression levels as 
compared to wildtype MDCK 
cells. Actin served as protein 
loading control.  
 
B) Densitometric quantification of 
Cav-1 protein levels in knock 
down and wildtype MDCK cells 
using ImageJ. Results are given in 
% of 100 % wildtype protein, 
showing an efficient Cav-1 knock 
down with 15 % residual protein 
expression.  
 
C) Cav-1 protein levels were 
standardized to actin, yielding 
similar ratios for all wildtype cells 
and considerably lower values for 
Cav-1 KD MDCK.  
 
One representative experiment is 
shown. 
 
 
 
Densitometric quantification of the remaining protein levels with ImageJ yielded a 
reduction in overall Cav-1 expression of 85 % when compared to a dilution series of 
wildtype MDCK cells (Figure 7 B). Standardization of Cav-1 to actin protein levels 
gave similar ratios for all wildtype samples with the values for the Cav-1 KD MDCK 
cells being considerably lower than for wildtype cells (0.5 and 0.6 for Cav-1 KD 
MDCK as compared to 1.8 – 2.6 for wildtype MDCK cells) (Figure 7 C).  
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Cav-1 protein levels were quantified for each fatty acid uptake assay carried out with 
Cav-1 KD MDCK cells in order to verify the stability of the protein knock down (see 
section 5.3.9). 
 
5.2 CD36 overexpression increases oleate uptake 
Initial experiments using CD36 overexpressing MDCK cells showed a moderate 
increase in fatty acid uptake as compared to control cells. Radioactive oleate uptake 
assays were performed to analyze whether CD36 mediated fatty acid uptake is 
modulated by different (free) oleate concentrations.   
 
5.2.1 CD36 mediated oleate uptake is similarly enhanced independent from free 
oleate concentrations 
To vary free oleate concentrations, CD36FLAG overexpressing MDCK cells were 
incubated with 3H-oleic acid bound to BSA in various proportions, starting from 
0.5:1 (50 µM oleate:100 µM BSA) up to 8:1 (800 µM oleate: 100 µM BSA) with 
BSA concentrations fixed at 100 µM.  
 
 
Figure 8: Variation of free oleate 
concentrations does not significantly 
influence CD36 mediated fatty acid 
uptake. 
 
CD36FLAG overexpressing as well as 
wildtype MDCK cells were incubated 
with 3H-oleic acid bound to BSA in 
various ratios (100 µM BSA, oleate 
changing, 3 Ci/mol specific activity) for 3 
h. Although CD36 mediated oleate 
uptake was increased more at higher 
oleate:BSA ratios (A) no significant 
difference was observed in comparison to 
lower ratios (B). 
 
The assay was performed in triplicates, 
error bars correspond to standard 
deviation. n=3 
 
 
 
Results 
 61 
Although CD36 mediated oleate uptake increased with higher oleate:BSA ratios 
(Figure 8 A) no significant difference to wildtype MDCK cells was evident as 
compared to lower ratios (Figure 8 B). Hence, for all following assays an oleate:BSA 
ratio of 2:1 was chosen in accordance with the standard protocols used in our 
laboratory. 
 
5.2.2 CD36 overexpression increases oleate uptake over a range of different 
oleate concentrations 
Different molar concentrations of oleate were tested in respect to their influence on 
CD36 mediated oleate uptake. Three different molarities were used ranging from 
20 – 600 µM, whereas oleate:BSA ratios remained constant at 2:1. The amount of 
incorporated oleate increased with rising molarity of the applied 3H-oleic acid 
(Figure 9 A).  
 
Figure 9: Influence of different 
oleate concentrations on CD36 
mediated fatty acid uptake.  
 
CD36FLAG overexpressing as well as 
wildtype MDCK cells were 
incubated with BSA bound oleate 
(oleate:BSA = 2:1) for 3 h. 
Different molar concentrations of 
oleate were used, ranging from 
20 µM (5 Ci/mol specific activity) 
over 200 µM to 600 µM (both 
0.5 Ci/mol specific activity). 
 
A) Oleate uptake of CD36FLAG and 
wildtype MDCK cells at different 
oleate molarities was determined as 
pmol oleate/µg total protein. 
Increasing molar concentrations of 
oleate caused an enhanced oleate 
uptake.  
 
B) Effect of CD36 overexpression 
on oleate uptake shown in % 
difference to the respective wildtype 
control. Only slight differences 
were observed between different 
samples.   
 
The assay was performed in 
triplicates (20 µM, 600 µM) or 
duplicates (200 µM), error bars 
correspond to standard deviation. 
n=1 
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When analyzing the effect of CD36 overexpression on fatty acid uptake in 
comparison to control cells no significant difference was observed between the 
various oleate molarities (Figure 9 B). A molar concentration of 200 µM oleate was 
subsequently chosen for further experiments, thus ensuring a sufficient amount of 
3H-oleate uptake for reliable readings of radioactivity. 
 
5.3 Quantification of CD36, FATP4 and ACSL1 protein amounts in correlation 
to oleate uptake 
The main body of this work incorporated 1) the measurement of fatty acid uptake in 
MDCK cells overexpressing CD36, FATP4 or ACSL1 protein by radioactive oleate 
uptake assays and 2) the quantification of CD36, FATP4 and ACSL1 protein 
expression by comparison to a recombinant protein standard.  
 
5.3.1 Preparation of recombinant FATP4FLAG protein standard 
A recombinant FLAG-tagged FATP4 protein standard was generated for 
quantification of CD36, FATP4 and ACSL1 proteins in MDCK cells. Two different 
variants of FATP4 protein were overexpressed in MDCK cells, which differed in the 
localization of the FLAG-tag. One protein lacked its membrane anchor to facilitate 
the purification process. Hence, two different kinds of FATP4 standard were used for 
subsequent western blotting, running at 72 kDa (C-terminal FLAG = FATP4FLAG) 
and 33 kDa (N-terminal FLAG = FLAG FATP4), respectively. 
Quantification of  affinity purified FATP4FLAG by western blotting yielded a 
concentration of 18.7 ng/µl in a total volume of 60 µl. A much higher quantity was 
obtained for FLAGFATP4, with 47.5 ng/µl in overall 120 µl sample volume 
(Figure 10 A, B).  
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Figure 10: Quantification of purified FLAG FATP4 protein. 
FLAGFATP4 protein was stably overexpressed in MDCK cells and afterwards purified using a FLAG-
tag based gel affinity system. Quantification of the purified protein was performed by SDS PAGE, 
with sample values being compared to a BSA standard curve. 30 µl of purified protein (= 1/4 of total 
sample volume) were loaded. 
A) SDS gel showing purified FLAGFATP4 protein, together with a BSA dilution series and purified 
wildtype cells serving as negative control. With coomassie brilliant blue staining the FLAGFATP4 can 
be detected at 33 kDa (arrow). 
B) Standard curve established from the BSA dilution series. The FLAGFATP4 sample loaded on the gel 
contained 1.4 µg of protein in 30 µl sample (black dot), yielding a final concentration of 47.5 ng/µl. 
 
5.3.2 Oleate uptake is significantly enhanced by FATP4 overexpression and 
correlates with FATP4 protein quantities 
Wildtype MDCK cells were infected with rising amounts of 0.1 – 6 µl FATP4 
adenovirus that correlated with an increase in FATP4 protein expression, ranging 
from 1,699 – 4,223 ng FATP4 protein/sample (Figure 11 A). Oleate uptake was 
significantly enhanced and correlated with increasing protein levels (Figure 11 B). 
Correlation of the enhancement in oleate uptake to FATP4 protein was comparable 
between the various approaches (Figure 11 C). Taken together, FATP4 mediated 
oleate uptake increased with enhanced protein expression levels while the specific 
oleate uptake per 1 ng FATP4 protein remained steady. 
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Figure 11: Titration of FATP4 
protein levels and its influence on 
oleate uptake.  
 
For FATP4 overexpression, wildtype 
MDCK cells were infected with 
increasing quantities of FATP4 
adenovirus. 
 
A) FATP4 protein levels correlated 
with the quantity of applied FATP4 
adenovirus as shown by western blot 
analysis. 
 
B) Sample analysis by radioactive 
oleate uptake assays. Cells were 
incubated with 3H-oleate (200 µM 
oleate:100 µM BSA, 0.5 Ci/mol 
specific activity) for 3 h. Oleate uptake 
increased significantly with enhanced 
amounts of FATP4 adenovirus used 
for infection.  
 
 C) Referring the increase in oleate 
uptake to FATP4 protein levels 
showed similar values for all 
investigated samples and was 
independent from FATP4 protein 
amounts.  
 
All assays were performed in 
triplicates, error bars correspond to 
standard deviation. n=3; * p < 0.05; ** 
p < 0.01 
 
 
 
 
 
 
5.3.3 Oleate uptake increases in correlation to the amount of overexpressed 
CD36 protein 
Wildtype MDCK cells were infected with different quantities of CD36FLAG 
adenovirus to analyze the influence of overexpressed CD36 protein on fatty acid 
uptake.  
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Figure 12: Oleate uptake is enhanced in CD36 overexpressing cells in correlation to the CD36 
protein amount. 
Wildtype MDCK cells were infected with increasing quantities of CD36FLAG adenovirus and effects 
analyzed by radioactive oleate uptake assays and western blots. 
A) Western blot analysis of protein levels. Samples were measured in duplicates or as single values 
(1 µl samples). CD36FLAG protein levels increased with rising amounts of CD36FLAG adenovirus.  
B) Cells were incubated with 3H-oleate (200 µM oleate:100 µM BSA, 0.5 Ci/mol specific activity) for 
3 h to assess oleate uptake. Samples were measured in triplicates. Increasing amounts of CD36FLAG 
adenovirus used for infection enhanced fatty acid uptake correspondingly. 
C) Correlation of oleate uptake to quantities of CD36 protein.  
Error bars correspond to standard deviation. n=3; ** p < 0.01; *** p < 0.001 
 
Corresponding to increasing amounts of adenovirus CD36 protein levels were 
enhanced. This effect was especially evident for cells infected with 8 µl adenovirus 
as compared to infections with 1 µl and 4 µl. Measured protein levels ranged from 
6.6 – 16.2 ng CD36/sample (Figure 12 A).Oleate uptake was significantly enhanced 
with rising concentrations of overexpressed CD36 protein as compared to control 
cells (Figure 12 B). When correlating the increase in oleate uptake to CD36 protein 
no obvious trend was observed. Calculated values reached from the uptake of 212 – 
460 pmol oleate/ng CD36FLAG protein (Figure 12 C).  
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Quantities of incorporated oleate as well as CD36 protein expression levels were 
considerably lower than previously observed for FATP4 overexpressing MDCK 
cells. 
In conclusion, infection of wildtype MDCK cells with increasing quantities of 
CD36FLAG adenovirus resulted in correspondingly enhanced amounts of 
overexpressed protein that correlated with increased oleate uptake. 
 
5.3.4 At comparable protein expression levels CD36 increases oleate uptake 
more than FATP4 
Comparable amounts of CD36 and FATP4 protein were overexpressed in MDCK 
cells to quantify the effects on oleate uptake. Wildtype MDCK cells were infected 
with 6 µl CD36FLAG adenovirus and a dilution series of FATP4 adenovirus, ranging 
from 0.001 – 0.5 µl. CD36 protein samples obtained from one out of three 
independently performed oleate uptake assays could not be quantified by western 
blotting due to too low protein amounts. The lowest concentration of FATP4 yielded 
similar protein levels as obtained by CD36 overexpression and was subsequently 
used for radioactive oleate uptake assays (Figure 13 A, B).  
CD36 overexpressing cells showed enhancement in fatty acid uptake by 7 pmol 
oleate/µg total protein (27 %) as compared to control cells. On the contrary, the 
effect of FATP4 overexpression at similar protein quantities caused a much smaller 
increase in oleate uptake, corresponding to 1 pmol oleate/µg total protein (4 %) 
difference to control cells (Figure 13 C).  
Results from oleate uptake assays were related to protein quantitites of CD36 and 
FATP4, thereby confirming a higher impact of CD36 than FATP4 on fatty acid 
uptake: CD36 overexpression caused a 3 x higher rise in oleate uptake of MDCK 
cells as observed for FATP4 (Figure 13 D).  
Conclusively, overexpression of CD36 and FATP4 at comparable protein quantities 
in MDCK cells shows a clearly higher increase in oleate uptake for CD36 MDCK 
than for FATP4 MDCK. This observation confirms a higher potency for CD36 than 
FATP4 in enhancing fatty acid uptake at low protein quantities.  
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Figure 13: Expression of similar CD36 and FATP4 protein amounts and their influence on 
oleate uptake.  
Wildtype MDCK cells were infected with CD36FLAG and various amounts of FATP4 adenovirus and 
results analyzed by western blotting and radioactive oleate uptake assays. 
A) + B) Quantitative analysis of CD36 and FATP4 protein levels by western blotting. Similar protein 
levels of CD36 and FATP were achieved at the lowest concentration of FATP4 used for adenoviral 
infection.  
C) Results obtained from radioactive oleate uptake assays. Cells were incubated with 3H-oleate 
(200 µM oleate:100 µM BSA, 0.5 Ci/mol specific activity) for 3 h. Only CD36 overexpression 
resulted in a clear increase in fatty acid uptake.  
D) When matching the results from oleate uptake assays to protein quantities the oleate uptake per 
1 ng protein was 3 x higher for overexpressed CD36 than FATP4 protein. 
Assays were performed in triplicates, error bars correspond to standard deviation. n=3, A), B), D): 
CD36 values n=2 
 
5.3.5 CD36 is expressed at significantly lower quantities than FATP4 but 
increases oleate uptake more than FATP4 when normalized to protein amounts 
In most experiments, FATP4 overexpression typically increased oleate uptake more 
than CD36. Thus, protein expression levels for both proteins were quantified and 
related to the respective alterations in fatty acid uptake.  
For better comparability, a high concentration of CD36FLAG adenovirus (6 µl) was 
chosen together with a low amount of FATP4 adenovirus (0.05 µl) for infection of 
wildtype MDCK cells. 
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Figure 14: Quantitative comparison of increases in fatty acid uptake as mediated by CD36 or 
FATP4 protein overexpression.  
Wildtype MDCK cells were infected with 6 µl CD36FLAG or 0.05 µl FATP4 adenovirus for protein 
overexpression. 
A) For radioactive oleate uptake assays cells were treated with 3H-oleate (200 µM oleate:100 µM 
BSA, 0.5 Ci/mol specific activity) for 3 h. CD36 as well as FATP4 overexpression enhanced oleate 
uptake as compared to control cells. 
B) Increases in fatty acid uptake that were mediated by CD36 and FATP4 overexpression are shown 
in % difference 
C) Quantification of protein amounts by western blotting revealed a 54 x higher expression for FATP4 
than CD36 protein.  
D) The oleate uptake related to ng protein CD36 or FATP4 was 33.5 x higher for overexpressed CD36 
than FATP4 protein. 
Values shown partially correspond to values depicted in Figures 16 and 17. All assays were performed 
in triplicates, error bars correspond to standard deviation. n=4; * p < 0.05 
 
Oleate uptake was enhanced by CD36 and FATP4 overexpression but only in the 
case of FATP4 overexpressing cells reached a significant increase when related to 
controls (Figure 14 A). The increase in fatty acid uptake was 20 % in CD36 
overexpressing cells, whereas FATP4 overexpression enhanced oleate uptake by 37 
% (Figure 14 B). Although the effects of both proteins on fatty acid uptake were 
within a comparable dimension, protein amounts for CD36 and FATP4 were 
significantly apart: protein quantification yielded a quantity of 13 ng CD36 protein as 
opposed to 701 ng FATP4 protein which corresponds to a 54 x higher expression of 
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FATP4 protein (Figure 14 C). Accordingly, when the increase in oleate uptake was 
referred to protein amounts, CD36 mediated the uptake of 201 pmol oleate/ng protein 
whereas FATP4 had a much smaller effect (6 pmol oleate/ng protein). This 
corresponds to a 33.5 x enhanced uptake caused by CD36 versus FATP4 
(Figure 14 D).  
In summary, overexpression of CD36 or FATP4 protein in MDCK cells increases 
oleate uptake by 20 - 37 % as compared to wildtype cells. Although CD36 protein is 
expressed in much lower quantities than FATP4 it has a more than 30 x higher effect 
on oleate uptake when referred to 1 ng of specific protein.  
 
5.3.6 Co-expression of CD36 and FATP4 has a synergistic effect on oleate 
uptake  
Co-expression experiments were performed to investigate whether two differentially 
localized enzymes, CD36 and FATP4, might cooperate in enhancing fatty acid 
uptake. Therefore, stable FATP4 MDCK cells were infected with CD36FLAG 
adenovirus and compared to MDCK cells overexpressing CD36 or FATP4 alone.  
Single overexpression of CD36 and FATP4 proteins increased fatty acid uptake in 
MDCK cells (Figure 15 A). FATP4 overexpression enhanced oleate uptake twice as 
much as CD36, resulting in 52 % versus 25 % increase as compared to control cells 
(Figure 15 B). Combined overexpression of both proteins additionally boosted fatty 
acid uptake and caused an increase that was considerably higher than calculated from 
single protein overexpression (122 % for CD36 and FATP4 co-expression as 
opposed to 25 % (CD36) + 52 % (FATP4) = 77 %) as depicted in Figure 15 B.   
Protein quantification again confirmed a strong difference in CD36 and FATP4 
expression levels, yielding 4.3 ng CD36 protein/sample as opposed to 539 ng FATP4 
protein/sample. In CD36 and FATP4 co-expressing MDCK cells, protein quantities 
were decreased to 42 % for CD36 (1.8 ng/sample) and 63 % for FATP4 (337 ng 
protein/sample) in comparison to single protein overexpression (Figure 15 C, D). No 
specific oleate uptake per 1 ng CD36 and FATP4 protein could be calculated in co-
expressing MDCK cells because within this experimental setup it was not possible to 
determine to which proportion every protein contributed to the observed effect.  
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Figure 15: Combined overexpression of CD36 and FATP4 proteins significantly enhances fatty 
acid uptake. 
To study the effect of combined protein overexpression, FATP4 MDCK were infected with 3 µl 
CD36FLAG adenovirus. Wildtype as well as MDCK cells overexpressing either CD36 or FATP4 served 
as control.  
A) + B) Samples were treated with 3H-oleate (200 µM oleate:100 µM BSA, 0.5 Ci/mol specific 
activity) for 3 h. Overexpression of CD36 and FATP4 alone increased oleate uptake. Co-expression of 
both proteins significantly boosted fatty acid uptake, resulting in a higher increase than calculated 
from data obtained by single protein overexpression. 
C) + D) Western blot analysis showed clearly different protein levels for CD36 and FATP4 upon 
overexpression. Co-expression resulted in reduction of both protein amounts.  
Values shown partially correspond to values depicted in Figure 19. Assays were performed in 
triplicates, error bars correspond to standard deviation. n=4; * p < 0.05; ** p < 0.01 
 
Nevertheless, it can be concluded that combined overexpression of CD36 and 
FATP4 protein significantly increases oleate uptake in MDCK cells. This effect is 
considerably more pronounced than calculated based on data from single protein 
overexpression.  
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5.3.7 Simultaneous overexpression of ACSL1 and CD36 significantly increases 
oleate uptake in comparison to single protein overexpression 
ACSL1FLAG MDCK cells were infected with 6 µl CD36FLAG adenovirus to 
investigate a possible cooperation of plasma membrane localized CD36 and 
intracellular ACSL1 in facilitating fatty acid uptake. Results were compared to 
MDCK cells overexpressing either CD36 or ACSL1 alone. 
Overexpression of ACSL1 or CD36 alone enhanced fatty acid transport to a 
comparable amount, resulting in 20 % increased oleate uptake as compared to 
wildtype control cells (Figure 16 A, B). Again, co-expression of both proteins 
significantly boosted fatty acid uptake. MDCK cells overexpressing ACSL1 and 
CD36 accepted 58 % more oleate than control cells, which corresponded to 150 % 
increase as compared to summation of the effects of single protein overexpression 
(58 % for CD36 and ACSL1 co-expression as opposed to 20 % (CD36) + 20 % 
(ACSL1) = 40 %) (Figure 16 A, B).  
Quantification of protein amounts by western blotting showed significantly different 
expression levels for both investigated proteins. ACSL1 MDCK cells contained 
1,198 ng ACSL1 protein/sample as opposed to 13 ng of CD36 protein/sample in 
CD36 overexpressing MDCK, resulting in a 92 x higher amount of ACSL1
 
versus 
CD36 protein (Figure 16 C).  
Accordingly high differences were observed in the amount of oleate uptake per 1 ng 
specific protein: 1 ng ACSL1 protein accounted for the uptake of 2 pmol oleate, as 
opposed to 201 pmol oleate uptake mediated by 1 ng CD36FLAG protein 
(Figure 16 D).  
In summary, CD36 and ACSL1 co-expression in MDCK cells displayed a synergistic 
influence on increasing oleate uptake. These results were in parallel with previous 
findings from CD36 and FATP4 co-expression experiments (see section 5.3.6). 
 
Results 
 72 
 
Figure 16: Synergistic effect of ACSL1 and CD36 co-expression on oleate uptake.  
Wildtype and ACSL1FLAG MDCK cells were infected with CD36FLAG adenovirus. Samples were 
analyzed by oleate uptake assays and co-expressing cells compared to ACSL1FLAG MDCK and 
CD36FLAG MDCK.  
A) + B) Cells were incubated with 3H-oleate (200 µM oleate:100 µM BSA, 0.5 Ci/mol specific 
activity) for 3 h. Overexpression of CD36 and ACSL1 alone equally increased oleate uptake by 20 %. 
Co-expression of both proteins boosted fatty acid uptake significantly, corresponding to 150 % 
increase as compared to summation of the effects obtained by single protein overexpression.  
C) Protein quantification by western blotting showed great differences between the investigated 
samples. ACSL1
 
 was expressed 92 x higher than CD36 protein. 
D) The specific oleate uptake per 1 ng protein was 100 x higher for CD36 than for ACSL1. 
Values shown partially correspond to values depicted in Figures 14 and 17. All assays were performed 
in triplicates, error bars correspond to standard deviation. n=4; * p < 0.05 
 
5.3.8 ACSL1 and FATP4 mediated increases in fatty acid uptake are not 
additive 
Like FATP4, ACSL1 belongs to the family of intracellular acyl-CoA synthetases that 
activate fatty acids by esterification with coenzyme A. ACSL1FLAG overexpressing 
cells were infected with 0.05 µl FATP4 adenovirus to study the effect of combined 
protein overexpression on fatty acid uptake.  
Oleate uptake was enhanced by single overexpression of both, ACSL1 and FATP4, 
with FATP4 having a significantly higher effect. In comparison to control cells, 
FATP4 enhanced fatty acid uptake by 37 % whereas ACSL1 overexpression caused 
only 20 % of increase (Figure 17 A, B).  
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Figure 17: ACSL1 and FATP4 co-expression does not considerably increase oleate uptake. 
To study the effect of ACSL1 and FATP4 co-expression ACSL1FLAG MDCK were infected with 
0.05 µl FATP4 adenovirus. Samples were compared to stable ACSL1FLAG overexpressing MDCK 
cells as well as to wildtype cells infected with FATP4 adenovirus.  
A) + B) Samples were incubated with 3H-oleate (200 µM oleate:100 µM BSA, 0.5 Ci/mol specific 
activity) for 3 h. Overexpression of ACSL1 and FATP4 alone increased oleate uptake, with FATP4 
overexpression having a more pronounced effect. Co-expression of both proteins did not significantly 
differ from overexpression of FATP4 alone and was smaller than calculated from single protein 
overexpression of both proteins. 
C) + D) Proteins were quantified by western blotting and yielded expression levels for ACSL1 and 
FATP4 within the same dimension.  
E) + F) The specific oleate uptake per 1 ng protein was in a comparable dimension for both 
investigated proteins.  
Values shown partially correspond to values depicted in Figures 14 and 16. Assays were performed in 
triplicates, error bars correspond to standard deviation. n=4; * p < 0.05 
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Although co-expression of the two proteins significantly increased oleate uptake as 
compared to control cells (Figure 17 A) this enhancement differed only slightly from 
the effect caused by FATP4 overexpression alone and was considerably lower than 
calculated from single effects (41 % for FATP4 and ACSL1 co-expression as 
opposed to 37 % (FATP4) + 20 % (ACSL1) = 57 %) (Figure 17 B).  
Corresponding protein amounts yielded roughly comparable quantities for single as 
well as combined overexpression for each candidate protein (Figure 17 C, D). 
ACSL1 was expressed at higher protein levels than FATP4, with quantities ranging 
from 928 – 1,198 ng for ACSL1 (Figure 17 C) and 701 – 790 ng for FATP4 per 
sample (Figure 17 D). Accordingly, when oleate uptake was referred to the specific 
protein amounts similar results were obtained for both investigated proteins. 
Overexpression of ACSL1 or FATP4 alone caused an uptake of 2.1 pmol, 
respectively 5.8 pmol, oleate per 1 ng protein (Figure 17 E, F).  
Taken together, co-expression of ACSL1 and FATP4 proteins did not significantly 
increase oleate uptake in comparison to single protein overexpression.  
 
5.3.9 Knock down of Cav-1 has no effect on oleate uptake independent from 
CD36 expression 
Cav-1 has been suggested as an interaction partner for CD36 in mediating fatty acid 
transport across the plasma membrane. Hence, Cav-1 KD MDCK were analyzed to 
investigate whether Cav-1 modulates CD36 facilitated oleate uptake in MDCK cells.  
Protein quantities of Cav-1 were assessed by western blotting in all Cav-1 KD 
samples (Figure 18 A).  
Densitometric analysis of protein bands yielded a residual protein expression of 10 – 
15 % for the investigated samples, thus verifying a high and stable knock down 
efficiency (Figure 18 B). Normalization of Cav-1 values to actin showed comparable 
ratios for all wildtype samples (1.0 – 2.0, 4.2 for the smallest amount of wildtype 
protein). The values calculated for the Cav-1 KD cells were much more lower (0.2 
and 0.3) and confirmed successful reduction of protein expression levels 
(Figure 18 C).  
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Figure 18: Quantification of 
Cav-1 knock down in MDCK 
cells used for oleate uptake 
assays.  
 
Knock down of Cav-1 in MDCK 
cells was established by RNAi 
and cells subsequently infected 
with CD36FLAG adenovirus.  
 
A) Quantification of Cav-1 
protein amounts in wildtype and 
knock down MDCK cells was 
performed by western blotting. 
Equal amounts for Cav-1 KD and 
100 % wildtype MDCK cell 
lysates were loaded together with 
a dilution series of wildtype 
MDCK cell lysates. Cav-1 KD 
MDCK cells display clearly 
diminished protein expression 
levels as compared to controls. 
Actin was used as loading 
control.   
 
B) Proteins bands were 
densitometrically quantified with 
ImageJ. Cav-1 KD cells 
(uninfected or infected with 
CD36FLAG adenovirus) showed an 
efficient knock down with 10 – 
15 % residual protein activity. 
Results are given in % of 100 % 
wildtype protein.  
 
C) Standardization of Cav-1 
protein levels to actin yielded 
similar ratios for most wildtype 
cells whereas ratios for Cav-1 
KD MDCK were considerably 
lower.  
 
Error bars correspond to standard 
deviation. n=4 
 
In radioactive oleate uptake assays, CD36 overexpression increased fatty acid uptake 
in wildtype and Cav-1 KD MDCK cells. Cav-1 depletion did not alter oleate uptake 
in wildtype MDCK cells but caused a slight change in CD36FLAG adenovirus infected 
Cav-1 KD cells that accounted for an 8 % increase as compared to CD36 
overexpressing wildtype cells (Figure 19 A). 
 
Results 
 76 
 
 
Figure 19: Cav-1 knock down has no effect on CD36 mediated oleate uptake.  
Wildtype as well as Cav-1 KD MDCK cells were infected with CD36FLAG adenovirus. The respective 
uninfected cell lines served as control.  
A) For fatty acid uptake assays cells were incubated with 3H-oleate (200 µM oleate:100 µM BSA, 
0.5 Ci/mol specific activity) for 3 h. CD36
 
overexpression increased oleate uptake in both investigated 
cell lines. Cav-1 knock down had no effect on fatty acid uptake in wildtype MDCK but caused a slight 
increase in CD36 overexpressing cells.  
 
 
B) Quantification of protein amounts by western blotting showed an increased CD36 protein level in 
Cav-1 KD as compared to wildtype cells.  
C) The specific increase in oleate uptake per 1 ng protein CD36 was similar for both investigated cell 
lines.   
Values shown partially correspond to values depicted in Figure 15. Assays were performed in 
triplicates, error bars correspond to standard deviation. n=4; * p < 0.05 
 
Quantification of CD36 protein amounts showed a higher expression level of CD36
 
protein in Cav-1 KD MDCK (6.6 ng/sample) as compared to CD36 overexpressing 
wildtype MDCK cells (4.3 ng/sample) which correlated to an increase by 53 % 
(Figure 19 B). When increases in oleate uptake were correlated to CD36 protein 
levels no significant difference was observed between wildtype and Cav-1 KD 
MDCK cells (Figure 19 C). 
In summary, within this experimental setup knock down of Cav-1 had no significant 
influence on oleate uptake in wildtype and CD36 overexpressing cells. 
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5.3.10 Overexpression of CD36 and FATP4 increases short term oleate uptake 
in correlation to protein amounts 
The majority of oleate uptake assays in this study was performed by incubating cells 
with radiolabeled oleate for 3 h. After this time, the activation of signaling cascades 
as well as transcriptional regulatory processes might have influenced fatty acid 
uptake. Thus, assays with a decreased incubation time of 5 min were conducted.  
For experiments, wildtype MDCK cells were infected with different amounts of 
CD36FLAG and FATP4 adenovirus. Protein amounts correlated with increasing 
quantities of adenovirus: CD36 samples showed an enhanced protein quantity from 
low (1 µl adenovirus, 8.2 ng CD36 protein/sample) to high (4 µl adenovirus, 27 ng 
CD36 protein/sample and 6 µl adenovirus, 25.9 ng CD36 protein/sample) virus 
concentrations (Figure 20 A). FATP4 protein amounts clearly increased with rising 
quantities of FATP4 adenovirus used for infection (371 ng, 4,715 ng and 7,825 ng, 
respectively) (Figure 20 B). Again, FATP4 protein was expressed at much higher 
levels than CD36FLAG protein. 
Oleate uptake was enhanced in correlation to rising protein amounts and was more 
prominent in FATP4 than CD36 overexpressing cells. Whereas CD36FLAG 
overexpression slightly enhanced fatty acid uptake by 11 – 15 %, FATP4 
overexpression increased oleate uptake by 7 - 92 %, respectively (Figure 20 C). 
Relating the increase in oleate uptake to CD36 and FATP4 protein amounts showed 
no clear tendency for CD36 samples. Ratios ranged from uptake of 1.1 pmol 
oleate/1 ng protein (4 µl) to 2.3 pmol oleate/1 ng protein (2 µl) (Figure 20 D). On the 
contrary, data calculated for FATP4 samples showed a clear trend: ratios of oleate 
uptake by 1 ng protein decreased with increasing quantities of overexpressed FATP4 
(Figure 20 E).  
Taken together, overexpressed CD36FLAG as well as FATP4 increase short term 
oleate uptake in MDCK cells. This effect is more pronounced for FATP4 
overexpression, with the rise in fatty acid uptake corresponding to increasing protein 
amounts.  
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Figure 20: Overexpression of CD36 and FATP4 increases short term oleate uptake.  
Wildtype MDCK cells were infected with increasing concentrations of CD36FLAG and FATP4 
adenovirus. Uninfected cells served as controls.  
A) + B) Western blot analysis of CD36 and FATP4 protein amounts. Protein quantities rise with 
increasing amount of respective adenovirus used for infection. FATP4 protein is expressed at much 
higher levels than CD36.  
C) Analysis of oleate uptake. Cells were incubated with 3H-oleate (200 µM oleate:100 µM BSA, 
2 Ci/mol specific activity) for 5 min. CD36 as well as FATP4 overexpression increased oleate uptake, 
with FATP4 having a much more prominent effect.  
D) + E) Assessment of the specific increase in oleate uptake per 1 ng protein. CD36 overexpression 
enhances fatty acid uptake more efficiently than FATP4 overexpression. The ratio of oleate uptake per 
1 ng protein FATP4 decreases with increasing protein quantities.  
All assays were performed in triplicates, error bars correspond to standard deviation. oleate uptake 
assays: n=4; western blots: FATP4: n=4, CD36FLAG 1 µl adenovirus: n=2, CD36FLAG 4 µl and 6 µl 
adenovirus: n=3, * p < 0.05; ** p < 0.01 
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5.4 Analysis of CD36, FATP4 and ACSL1 localization by immunofluorescence 
microscopy 
In scientific literature, different cellular localizations have been described for CD36, 
FATP4 and ACSL1. Hence, MDCK cells were analyzed by immunofluorescence to 
identify the respective localization of each protein. Stable ACSL1FLAG MDCK  and  
FATP4 MDCK as well as CD36FLAG adenovirus infected wildtype MDCK were used 
for analysis of single protein overexpression. FATP4 and ACSL1FLAG overexpressing 
cells were infected with CD36FLAG or FATP4 adenovirus to analyze protein 
localization upon co-expression.  
 
5.4.1 CD36 is expressed at the plasma membrane and intracellularly 
For analysis of CD36 localization, CD36FLAG MDCK  cells  were  stained  using  a     
ms-?-CD36 antibody and a rb-?-FLAG antibody. Each of the two antibodies 
detected a differently localized pool of CD36FLAG protein within the same cell: the 
ms-?-CD36 antibody stained CD36 in the plasma membrane (Figure 21 A) as 
opposed to the rb-?-FLAG antibody that showed an intracellular signal 
(Figure 21 B). Overlay of both pictures confirmed the differential localization 
(Figure 21 C).  
 
 
Figure 21: Overexpressed CD36FLAG is  found  in  two  differentially  localized  pools  in  MDCK  
cells. 
Wildtype MDCK cells were infected with CD36FLAG adenovirus and subsequently stained using a   
ms-?-CD36 antibody (A) or a rb-?-FLAG antibody (B). Two differently localized pools of 
CD36FLAG were detected within the same cell, depending on the antibody. The ms-?-CD36 antibody 
shows a signal for CD36FLAG located in the plasma membrane (A) whereas the rb-?-FLAG antibody 
detects CD36FLAG in the cytoplasm (B). An overlay of both pictures confirms the different 
localization (C). Pictures from a representative sample are shown. Dimension bars are 20 µm.  
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5.4.2 FATP4 is located at the endoplasmic reticulum 
To analyze the intracellular expression pattern of FATP4, stably overexpressing 
retroviral FATP4 MDCK cells as well as FATP4 adenovirus infected wildtype 
MDCK cells were used.  
After staining with an ?-FATP4 antibody all samples showed a typical network like 
structure surrounding the cellular nucleus (Figure 22). This pattern is known to be 
characteristic for proteins localized to the endoplasmic reticulum and is in 
accordance with former experimental data from our group (Krammer et al., 2011)  
(Milger et al., 2006) (Digel et al., 2011). FATP4  localization  was the same for 
retroviral infected, stable overexpressing as well as adenoviral infected, transiently 
overexpressing MDCK cells. 
 
Figure 22: FATP4 localizes to the ER when overexpressed in MDCK cells.  
Samples were stained using a rb-?-FATP4 antibody and analyzed by fluorescence microscopy. 
FATP4 MDCK cells display a characteristic network like structure, typical for proteins localized to 
the endoplasmic reticulum.  
A picture from a representative sample is shown. The dimension bar is 20 µm. 
 
5.4.3 Co-expression of CD36 and FATP4 does not change either protein 
localization 
Stable FATP4 MDCK cells were infected with CD36FLAG adenovirus in order to 
analyze the localization of each protein when co-expressed. For detection of 
CD36FLAG protein  the  ms-?-CD36  antibody  was  chosen,  which  before  had  
specifically detected plasma membrane localized CD36.  
Immunofluorescence analysis showed that co-expression of CD36 and FATP4 did 
not change the localization of either protein (Figure 23). FATP4 remained to show a 
strong signal within the endoplasmic reticulum (Figure 23 A) whereas CD36FLAG 
was detected at the plasma membrane (Figure 23 B). An overlay of the single 
pictures confirmed a clearly distinct localization of both proteins within the same cell 
(Figure 23 C).  
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Figure 23: Co-expression of CD36 and FATP4 does not change the localization of either protein.   
Combined overexpression of CD36 and FATP4 in MDCK cells was achieved by infection of a stably 
overexpressing FATP4 cell line with CD36FLAG adenovirus. Samples were stained by incubation with  
a rb-?-FATP4 antibody (FATP4, green) and a ms-?-CD36 antibody (CD36FLAG, red).  
A) FATP4 protein is found in the network like structures of the endoplasmic reticulum.  
B) CD36 localizes to the plasma membrane.  
Overlay of the single pictures confirms the distinct localization of the investigated proteins.  
Pictures from representative samples are shown. Dimension bars are 20 µm. 
 
5.4.4 ACSL1 is expressed on mitochondria and does not alter the localization of 
CD36 or FATP4 
Stable ACSL1FLAG MDCK were analyzed by immunofluorescence before and after 
infection with CD36FLAG and FATP4 adenovirus. Overexpressed ACSL1 protein was 
found on worm like structures in all investigated samples, typical for a localization 
on mitochondria. This observation is in accordance with previous results from our 
group, showing a co-localization of ACSL1FLAG with a mitochondrial marker (Milger 
et al., 2006) (Zhan et al., 2012).  
Additional  overexpression  of  either  CD36  or  FATP4  protein  did  not  change  the  
distribution pattern of ACSL1FLAG within  the  analyzed  cells  (Figure  24  A,  D).  
Analysis of CD36 and FATP4 proteins in the respective samples also displayed no 
alterations in localization: CD36 was expressed at the plasma membrane 
(Figure 24 B) whereas FATP4 was still found on the endoplasmic reticulum 
(Figure 24 E). As overexpressed CD36FLAG and ACSL1FLAG both possessed a FLAG-
tag, co-staining of the two proteins occured (Figure 24 A). Due to the lack of an 
ACSL1 antibody for immunofluorescence this drawback could not be avoided. An 
overlay of the single pictures of ACSL1 and CD36 or FATP4 confirmed a clearly 
distinct localization for ACSL1 and CD36 (Figure 24 C) as well as for ACSL1 and 
FATP4 (Figure 24 F) within the same cell.  
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Figure 24: Co-expression of ACSL1 with CD36 or FATP4 has no influence on intracellular 
protein localization. 
Stable ACSL1FLAG MDCK cells were either infected with CD36FLAG or FATP4 adenovirus in order to 
achieve a combined overexpression. Samples were stained by incubation with ms-?-FLAG 
(ACSL1FLAG), rb-?-FLAG (ASCL1FLAG), ms-?-CD36 (CD36FLAG) or rb-?-FATP4 (FATP4) antibodies 
and anlyzed by fluorescence microscopy. Co-expression of ACSL1 and CD36 or ACSL1 and FATP4 
did not influence the localization of either protein.  
A) ACSL1 localizes to worm like structures representing mitochondria.  
B) CD36 protein is detected  in the plasma membrane.  
C) ACSL1 and CD36 show a clearly distinct localization within the same cells.   
D) Mitochondrial expression pattern of ACSL1 in MDCK cells co-expressing FATP4.  
E) FATP4 is located on the endoplasmic reticulum.  
F) Overlay of single sections shows a distinct localization for ACSL1 and FATP4 proteins. 
Pictures from representative samples are shown. Dimension bars are 20 µm. 
 
5.4.5 Cav-1 knock down does not change CD36 localization 
For immunofluorescence, wildtype and Cav-1 KD MDCK cells were infected with 
CD36FLAG adenovirus to analyze the cellular localization of CD36. Successful knock 
down of Cav-1 was verified by a diminished number of stained cells in Cav-1 KD 
MDCK as compared to controls (Figure 25 A, D). CD36 protein was localized to the 
plasma membrane, with no obvious alterations in expression pattern in Cav-1 KD 
MDCK as opposed to wildtype MDCK cells (Figure 25 B, E).  
 
 
 
 
 
Results 
 83
 
 
  
Figure 25: CD36 localization is not influenced by Cav-1 KD in MDCK cells.  
Wildtype and Cav-1 KD MDCK cells were infected with CD36FLAG adenovirus and stained for Cav-1 
(green) and CD36 (red).  
A-C) Wildtype MDCK cells show Cav-1 expression together with plasma membrane localized CD36 
protein.  
D-F) Cav-1 KD MDCK cells show a diminished number of stained cells as compared to controls. 
Localization of CD36 is uneffected, with CD36 still visible at the plasma membrane. 
Pictures from representative samples are shown. Dimension bars are 20 µm. 
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6. Discussion 
Regulation of fatty acid uptake is essential for maintaining lipid homeostasis and for 
prevention of diseases. Two mechanism are considered for fatty acid uptake: passive 
diffusion across the plasma membrane and protein facilitated transport. Proteins that 
have been implicated in fatty acid uptake include the fatty acid translocase CD36 as 
well as the acyl-CoA synthetases FATP4 and ACSL1. It has been shown that all 
three proteins enhance fatty acid uptake upon overexpression but there is an ongoing 
debate about their localization and mode of action. To gain a better understanding of 
how each protein may contribute to cellular fatty acid uptake, this study correlated 
molar amounts of overexpressed CD36, FATP4 and ACSL1 to the increase in fatty 
acid uptake. MDCK cells allowed a generalized analysis and unbiased quantification 
of this process, because they are not specialized in fatty acid uptake.   
 
6.1 FATP4 overexpression increases fatty acid uptake more than CD36 
overexpression – due to higher expression levels 
Various studies previously verified a role for CD36 and FATP4 in fatty acid uptake. 
The transmembrane glycoprotein CD36 binds long chain fatty acids (Baillie et al., 
1996) and mediates fatty acid uptake (Ibrahimi et al., 1996). Its overexpression 
increased palmitate uptake in C2C12 muscle cells (Bastie et al., 2004) and enhanced 
fatty acid transport in rat skeletal muscle (Nickerson et al., 2009). These findings 
correlate with results from our own group that evidenced an increase in fatty acid 
uptake upon CD36 overexpression in COS cells (Ehehalt et al., 2008) and human 
hepatoma cells (Krammer et al., 2011).  
The acyl-CoA synthetase FATP4 has also been implicated in the regulation of fatty 
acid uptake. Although its localization and mode of action remain a matter of 
discussion, FATP4 overexpression was shown to increase fatty acid uptake in 
Hek293 cells (Stahl et al., 1999) and rat skeletal muscle (Nickerson et al., 2009). 
Again, theses findings correlate with previous data from our group that showed an 
increase in fatty acid uptake upon FATP4 overexpression in COS cells (Milger et al., 
2006), C2C12 cells (Digel et al., 2011) and 3T3-L1 adipocates (Zhan et al., 2012). 
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Fatty acid uptake in MDCK cells was consistently increased more by FATP4 than 
CD36 overexpression. During this study, the comparison of oleate uptake in CD36 
and FATP4 overexpressing MDCK cells confirmed a higher increase for FATP4 than 
CD36 cells as related to controls. It seemed conclusive that FATP4 had a higher 
impact on fatty acid uptake than CD36. Surprisingly, when protein levels were 
quantified CD36 was expressed at much lower levels than FATP4. Although FATP4 
increased oleate uptake nearly twice as much as CD36, calculation of the oleate 
quantity taken up by 1 ng overexpressed protein revealed a more than 30 x higher 
efficiency for CD36. This finding reversed the assumption that FATP4 is more 
potent in mediating intracellular fatty acid uptake than CD36. However, it has to be 
taken in account that CD36 and FATP4 differ in their molecular weights (55 kDa for 
CD36FLAG versus 72 kDa for FATP4). Correspondingly, for example similar protein 
amounts of CD36 and FATP4 would equal about one third more CD36 than FATP4 
molecules. Although the difference in oleate uptake calculated for 1 ng protein would 
then be reduced by a fraction CD36 still would be more considerably efficient than 
FATP4 in facilitating fatty acid uptake. 
Yet, it had to be considered that the striking difference in protein amounts might at 
least partially influence the analytical outcome. If CD36 and/or FATP4 mediate fatty 
acid uptake by a saturable process it would be likely that at low protein amounts the 
increase in fatty acid uptake would be higher than at high protein amounts. With 
increasing protein quantities the process would come close to saturation, leading to a 
proportionally smaller rise in fatty acid uptake. To test this hypothesis, CD36 and 
FATP4 were overexpressed at comparable low protein amounts. This time, CD36 
increased oleate uptake considerably more than FATP4 (27 % versus 4 %) with 
FATP4 overexpressing cells barely showing a difference in fatty acid uptake as 
compared to control cells. Comparing the effect of FATP4 on fatty acid uptake at 
low and high protein expression levels revealed a striking difference: at 10 ng 
FATP4 protein/sample oleate uptake was enhanced by 44 pmol oleate/ng protein 
whereas at 701 ng FATP4 protein/sample the increase in fatty acid uptake was 
6 pmol oletae/ng protein. Again, these findings would indicate a saturable process for 
both, CD36 and FATP4 mediated fatty acid uptake.  
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When MDCK cells were infected with increasing amounts of CD36 and FATP4 fatty 
acid uptake was increased in correlation to rising CD36 and FATP4 protein levels. 
Interestingly, expression levels of FATP4 could be easily varied within a broad range 
whereas CD36 expression rates were limited to low concentrations of several ng per 
12-well and sample. Higher dilutions of adenovirus used for infection allowed for the 
expression of very small protein quantities which no longer effected oleate uptake 
whereas high amounts of adenovirus killed the infected cells. 
As protein overexpression was achieved by adenoviral infection in both cases it 
seems unlikely that methodical restrictions might be the cause that CD36 and FATP4 
proteins were expressed at such different levels. Even if adenoviral titres would have 
been much higher for FATP4 than CD36 (which was not indicated by 
immunfluorescence experiments) they could not have accounted for such a big 
difference in expression levels. The best explanation at this point seems that cells 
tolerated FATP4 overexpression better and over a broader range than CD36 
overexpression. The reasons for this remain speculative but spatial restriction could 
come in mind. As shown before, we suggested a model that places CD36 at the 
plasma membrane for mediating fatty acid transport. The plasma membrane is 
limited in space and might therefore prevent high amounts of CD36 overexpression, 
thereby limiting the expression rates of functionally active CD36 protein. A distinct 
half-life of both proteins might also contribute to the observed differences in protein 
quantities but was not tested in our model. 
 
6.2 Cav-1 does not influence CD36 mediated fatty acid uptake 
Cav-1 is a membrane protein that contributes to the formation of cell membrane 
invaginations (caveolae) that serve as signaling platforms. It was suggested that  
Cav-1 is involved in fatty acid uptake via its lipid binding site (Trigatti et al., 1999) 
in accordance with its high expression rate in adipocytes. The role of Cav-1 in CD36 
facilitated fatty acid transport is still a matter of debate as there are conflicting 
opinions stating or denying an interaction of CD36 and Cav-1. Evidence for a 
regulation of CD36 function in fatty acid uptake by Cav-1 was obtained from 
experiments with Cav-1 knock out mouse embryonic fibroblasts. In wildtype cells, 
CD36 was localized intracellularly and at the plasma membrane, whereas in Cav-1 
knock out cells the surface expression of CD36 was abolished. The altered 
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localization of CD36 resulted in decreased fatty acid uptake, indicating that Cav-1 is 
needed for proper plasma membrane localization and function of CD36 (Ring et al., 
2006). Controversially, a former study conducted in CHO cells and C32 cells stated 
that CD36 was localized to the plasma membrane but not found in caveolae (Zeng et 
al., 2003). Another group overexpressed various amounts of Cav-1 in Hek293 cells 
and concluded that fatty acid transport was modulated by Cav-1. As results were 
obtained in absence of CD36, it was suggested that Cav-1 mediated fatty acid 
transport occurred independent from CD36 expression (Meshulam et al., 2006). 
Controversially, in chinese hamster ovary cells CD36 was expressed in detergent-
resistant membranes together with Cav-1 but failed to enhance oleate uptake 
independent from protein expression levels (Eyre et al., 2008). 
In this study, a knock down of Cav-1 in MDCK cells was performed to shed some 
light on a potential interaction of CD36 and Cav-1 in fatty acid uptake. Residual 
protein levels ranged from 10 - 15 %, confirming an efficient and stable reduction in 
protein quantities. In our model system, Cav-1 knock down did not change the CD36 
localization at the plasma membrane of wildtype and Cav-1 KD cells. A slight 
increase in fatty acid uptake was observed in Cav-1 KD MDCK cells overexpressing 
CD36 as compared to CD36 overexpressing wildtype cells. The Cav-1 KD cells 
showed higher CD36 protein expression levels thus indicating that increase in fatty 
acid uptake was due to the higher protein quantity. 
Contradictory to results obtained by other groups, we could not confirm a regulation 
of CD36 by Cav-1 expression with reference to localization or function in fatty acid 
uptake. Previous studies had stated that Cav-1 knock down impaired CD36 mediated 
fatty acid transport, however this was not the case in Cav-1 KD cells overexpressing 
adenoviral CD36. Based on the observation that CD36 protein expression was 
slightly enhanced in Cav-1 KD cells, it could be speculated that knock down of Cav-
1 facilitates adenoviral infection thereby increasing CD36 protein expression levels. 
In conclusion, Cav-1 knock down did neither change the localisation nor the 
functions of CD36 in fatty acid uptake in MDCK cells. As reviewed by Glatz  et al. 
(Glatz et al., 2010), controversial results for the interaction of CD36 and Cav-1 
might result from tissue- or cell type-specific differences in CD36 function.  
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6.3 CD36 and FATP4 are differentially localized and enhance fatty acid uptake 
by distinct mechanisms 
Different models have been suggested for enhancing fatty acid transport, involving 
intracellular as well as plasma membrane localized proteins. CD36 has been 
described as a plasma membrane glycoprotein (reviewed by (Silverstein and 
Febbraio, 2009)) that can be translocated from intracellular sites to the PM where it 
enhances FA uptake (Bonen et al., 2000).  
During this study, the cellular localisation of overexpressed CD36FLAG was analyzed 
by immunofluorescence. Two different antibodies were used, one targeting the CD36 
protein whereas the second antibody bound to the C-terminal FLAG-tag. A plasma 
membrane localisation was confirmed for CD36 but interestingly the two antibodies 
detected different pool of CD36FLAG protein within the same cell. The α-CD36 
antibody stained CD36 in the plasma membrane whereas the α-FLAG antibody 
showed an intracellular signal.  
The phenomenon of two diverse antibodies targeting the same protein but detecting 
differently localized pools has been detected before, such as for Cav-1 (Luetterforst 
et al., 1999). A possible explanation might be that antibody accessibility could be 
blocked depending on the protein localization. Furthermore, glycosylation is likely to 
be involved in trafficking of CD36 to the plasma membrane (Hoosdally et al., 2009) 
and might influence proper antibody binding.. Accordingly, inappropriately 
glycosylated CD36 would be found at a cytoplasmic localization and could only be 
recognized by an α-FLAG antibody. However, no CD36 was detected in the 
endoplasmic reticulum 
We assume, that only plasma membrane localized CD36 is functionally active in 
mediating fatty acid uptake. This is in accordance with other studies that verified a 
plasma membrane localization of CD36 in combination with increased fatty acid 
uptake. Exemplarily, plasma membrane localization of CD36 was required for 
enhancing oleate uptake in rat hepatoma cells (Eyre et al., 2007) and insulin 
mediated translocation of CD36 from an intracellular localization to the sarcolemma 
of cardiac myocytes increased fatty acid uptake (Luiken et al., 2002). CD36 can be 
inhibited by treatment with sulfo-N-succinimidyl oleate (SSO), leading to decreased 
fatty acid uptake in adipocates (Pohl et al., 2005). As SSO is not membrane 
permeable, only plasma membrane localized CD36 is blocked, indicating that  CD36 
facilitates fatty acid uptake directly at the plasma membrane. It is therefore likely, 
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that the effect of CD36 on oleate uptake has rather been underestimated in this study 
as protein quantification by western blotting did not differentiate between 
intracellular and plasma membrane localized CD36. A reliable quantification of 
plasma membrane localized CD36 alone would require a subcellular fractionation, 
with subsequent western blotting.  
In the case of FATP4, different localizations and functions are discussed. On the one 
hand, FATP4 has been described as fatty acid transport protein which is localized in 
the plasma membrane (Stahl et al., 2001; Doege and Stahl, 2006) but controversial 
studies indicated an intracellular localization at the endoplasmic reticulum (Jia et al., 
2007; Lobo et al., 2007). This would imply an indirect effect for FATP4 on fatty acid 
uptake, mediated by its enzymatic activity.  
During this study, we have consistently detected overexpressed FATP4 at the 
endoplasmic reticulum of MDCK cells. This finding is in accordance with previous 
observations from our group that equally showed FATP4 localized to the 
endoplasmic reticulum of MDCK cells (Milger et al., 2006). It seems reasonable to 
conclude, that in our model system FATP4 is located intracellularly at the 
endoplasmic reticulum and enhances fatty acid uptake indirectly by its enzymatic 
activity. Free fatty acids are metabolically trapped by esterification with 
coenzyme A, causing a concentration gradient of extra- to intracellular free fatty 
acids that drives fatty acid uptake.  
The majority of fatty acid uptake assays in this study was performed by incubation of 
the respective samples with radioactive oleate for 3 h. After this time, in addition to 
the overexpressed proteins also signaling processes, transcriptional regulation and 
energy storage in lipid droplets influence fatty acid uptake. This situation probably 
mirrors metabolic conditions better than short term oleate but might also complicate 
the evaluation of CD36 and FATP4 effect on fatty acid transport. Additionally, 
proteins might facilitated fatty acid uptake differently at different time points.   
Hence, experiments with an incubation time of 5 min were performed in MDCK 
cells that overexpressed increasing amounts of CD36 and FATP4 protein. In 
accordance with oleate uptake measured after 3 h fatty acid uptake increased with 
rising amounts of FATP4 protein. CD36 overexpressing MDCK cells showed the 
similar tendency but effects were very small, probably due to the overall low 
increase of fatty acid uptake.  
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In summary, CD36 and FATP4 are differentially localized and enhance fatty acid 
uptake by different mechanisms: CD36 is located in the plasma membrane where it 
enhances fatty acid transport whereas FATP4 is localized at the endoplasmic 
reticulum and metabolically traps intracellular fatty acids by esterification with 
coenzyme A. CD36 and FATP4 mediated oleate uptake plays a role in initial 
transport as well as in long-term uptake. 
 
6.4 Transport and metabolic trapping act synergistically to increase fatty acid 
uptake 
After assigning different localizations and modes of action to CD36 and FATP4 we 
wondered whether these proteins might act in cooperation for enhancing fatty acid 
uptake. One model for fatty acid uptake is the vectorial acylation hypothesis that 
proposes a cooperation of fatty acid transport across the plasma membrane with 
subsequent activation (Black and DiRusso, 2003).  
This model could nicely be applied to our system, with CD36 acting as transport 
protein and FATP4 and ACSL1 catalyzing fatty acid activation. In our system, fatty 
acid transport and activation would be only functionally coupled whereas vectorial 
acylation is often associated with additional spatial coupling (Zou et al., 2003; Doege 
and Stahl, 2006).  
Combined overexpression of CD36 and FATP4 did not change either protein 
localization , suggesting that also the functional mechanisms would be unaltered. Co-
expression of CD36 and FATP4 increased oleate uptake significantly more than 
calculated from  results obtained by single protein overexpression.  
Remarkably, the respective protein quantities of CD36 and FATP4 were lower in co-
expressing cells as compared to single overexpression, thus making the synergistic 
increase in fatty acid uptake even more pronounced. These results strengthen our 
hypothesis that CD36 and FATP4 might act together in increasing fatty acid uptake. 
If this assumption was correct, CD36 would show a similar behaviour in combination 
with other acyl-CoA synthetases, such as ACSL1. Contrarily, co-expression of two 
enzymes acting in the same manner, like the two acyl-CoA synthetases FATP4 and 
ACSL1, would enhance fatty acid uptake to a smaller extent.  
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Co-expression experiments were performed for CD36 and ACSL1 as well as for 
FATP4 and ACSL1. Initial immunofluorescence analysis confirmed the intracellular 
localization of ACSL1 on mitochondria. As previously observed for CD36 and 
FATP4, neither protein localization was altered upon combined overexpression. As 
predicted, CD36 and ACSL1 co-expression in MDCK cells displayed a synergistic 
influence on increasing oleate uptake in agreement with our data from CD36 and 
FATP4 co-expression experiments. On the contrary, co-expression of ACSL1 and 
FATP4 proteins caused a smaller increase in fatty acid uptake than calculated by 
summation of the effects caused by single protein overexpression.  
It seems evident, that oleate uptake mediated by intracellular enzymes targets only 
one metabolic mechanism and is limited by the transport rate of fatty acids across the 
plasma membrane and their intracellular accumulation. Co-expresssion of CD36 and 
FATP4 or ACSL1 on the other hand enhances fatty acid uptake by pushing two 
different mechanisms (fatty acid transport and activation). 
 
6.5 Conclusion 
Cellular fatty acid uptake can be facilitated by plasma membrane localized as well as 
intracellular proteins through different mechanisms. CD36 is a transmembrane 
glycoprotein that can be translocated from an intracellular pool to the plasma 
membrane where it binds fatty acids and mediates their transport across the lipid 
bilayer. FATP4 and ACSL1 are intracellular enzymes that activate fatty acids by 
esterification with coenzyme A, leading to metabolic trapping.  
In MDCK cells, overexpressed CD36 was detected at the plasma membrane as well 
as at an intracellular localization. Based on previous data we assumed only the 
plasma membrane localized CD36 to be functionally active in facilitating fatty acid 
uptake. FATP4 and ACSL1 were expressed intracellularly at the endoplasmic 
reticulum (FATP4) and on mitochondria (ACSL1). Co-expression of CD36 and 
FATP4 or ACSL1 with CD36 or FATP4 did not alter either protein localization. 
Knock down of Cav-1 did neither change CD36 localization nor influence fatty acid 
uptake in wildtype or CD36 overexpressing cells, concluding that Cav-1 is not 
required for CD36 mediated fatty acid uptake in MDCK cells.  
CD36 was expressed at much lower protein levels than FATP4 and limited in its 
maximal protein quantity, maybe due to spatial limitations at the plasma membrane. 
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It showed a considerably higher potency for increasing fatty acid uptake than 
FATP4. Low protein amounts of FATP4 led to a greater increase in oleate uptake per 
1 ng protein when contrasted with high expression levels. This hints at a saturable 
process of protein mediated fatty acid uptake that might also apply to CD36. 
Increasing quantities of overexpressed CD36 or FATP4 protein correlated with 
enhanced oleate uptake after 3 h of oleate incubation. A similar tendency was shown 
in short term oleate uptake after 5 min, indicating that CD36 and FATP4 play a role 
in short as well as long term fatty acid uptake. 
Co-expression of CD36 with either acyl-CoA synthetase, FATP4 or ACSL1, resulted 
in enhanced fatty acid uptake that was higher than could be expected from single 
protein overexpression. On the contrary, combined overexpression of FATP4 and 
ACSL1 resulted in only a slight increase of fatty acid uptake. It seems conclusive, 
that CD36 interacts with the acyl-CoA synthetases FATP4 and ACSL1 to enhance 
fatty acid uptake according to the concept of vectorial acylation: a fatty acid transport 
protein (CD36) ccoperates with an intracellular enzyme (FATP4, ACSL1) that 
activates fatty acids for downstream metabolism. In the case of CD36 and FATP4 or 
ACSL1, there would be a functional but no spatial coupling. No cooperation is 
possible between FATP4 and ACSL1 because they act in the same manner and target 
the same pathways when increasing fatty acid uptake. As both proteins are assumed 
to work near their maximum capacity their action is limited by the diffusion rate of 
fatty acids into the cell as well as by the accumulation of intracellular fatty acids. By 
interaction with the fatty acid transporter CD36 fatty acid uptake is not longer 
restricted by the diffusion rate, resulting in a much higher efficiency. 
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6.6 Suggestion of a model for facilitated fatty acid uptake involving CD36, 
FATP4 and ACSL1 
We suggest a model for facilitated fatty acid uptake with CD36 localized at the 
plasma membrane and an intracellular localization for FATP4 (endoplasmic 
reticulum) and ACSL1 (mitochondria). Fatty acid uptake is mediated by two 
different mechanisms depending on the respective protein localization: facilitated 
transport across the plasma membrane by CD36 and intracelluar activation of fatty 
acids by FATP4 and ACSL1. 
The glycoprotein CD36 is localized to the plasma membrane where it directly 
facilitates fatty acid transport into the cell, for example by lowering the activation 
energy that is necessary for a fatty acid carboxyl group to transverse through an 
apolar lipid bilayer (Abumrad et al., 1999) or by binding of fatty acids close to the 
extracellular side of the plasma membrane. 
For intracellular acyl-CoA synthetases, like FATP4 and ACSL1, it was suggested 
that they enhance fatty acid uptake indirectly by metabolic trapping (Mashek and 
Coleman, 2006). The activation of intracellular fatty acids is mediated by 
esterification with coenzyme A, consequently preventing fatty acids from diffusing 
back out of the cell and simultaneously decreasing the amount of free fatty acids in 
the cytoplasm. The gradient from extra- and intracellular free fatty acid concentration 
subsequently enhances fatty acid uptake (Figure 26 A).  
As CD36 mediates fatty acid uptake by a different mechanism than FATP4 and 
ACSL1 it seems a reasonable assumption that CD36 and the acyl-CoA synthetases 
may act in cooperation. In this model, co-expression of CD36 with FATP4 or 
ACSL1 would increase fatty acid uptake more than single protein overexpression due 
to an increased fatty acid translocation across the plasma membrane (CD36) 
followed by immediate activation by acyl-CoA synthetases (FATP4, ACSL1). Co-
expression of FATP4 and ACSL1 on the other hand would not significantly alter 
fatty acid uptake in comparison to single overexpression of either protein as both 
enzymes are expected to work close to their maximum capacity. Therefore, the effect 
of a combined protein overexpression of FATP4 and ACSL1 on fatty acid uptake 
would be limited by the transport rate of fatty aids into the cell. (Figure 26 B).  
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Figure 26: Model for facilitated fatty acid uptake mediated by CD36, FATP4 and ACSL1.  
A) Cellular fatty acid uptake is increased by the single overexpression of either CD36 (plasma 
membrane), FATP4 (endoplasmic reticulum) or ACSL1 (mitochondria) as compared to control cells. 
CD36 directly facilitates fatty acid uptake over the plasma membrane whereas the acyl-CoA 
synthetases FATP4 and ACSL1 activate intracellular free fatty acids to make them available for 
further downstream metabolism.  
B) The combined overexpression of CD36 with FATP4 or CD36 with ACSL1 enhances fatty acid 
uptake more than expected from summation of the single effects of both proteins. On the contrary, the 
overexpression of FATP4 with ACSL1 increases fatty acid uptake more than single expression of 
either protein but less than summation of the respective single effects.   
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